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1 INTRODUCTION 
Micronutrient deficiencies are very common in developing regions of the world 
although they are seen in industrialized nations as well. It affects all age groups 
but young children and women of reproductive age tend to be at the highest risk 
of developing micronutrient deficiencies. Worldwide, the three most common 
forms of micronutrient malnutrition are iron, vitamin A, and iodine deficiencies. It 
is estimated that over 2 billion people are anemic, nearly 2 billion have 
inadequate iodine nutrition, and 254 million preschool-aged children are vitamin 
A deficient. Even moderate levels of these deficiencies can have serious 
detrimental effects on human function (World Health Organization, 2000). 
The high prevalence of Iron deficiency and its subsequent anemia in different 
age groups of most provinces of Iran has been shown in two studies of 
"National Integrated Micronutrient Survey (NIMS report, 2003) 2000" and 
"National Food Consumption Survey-2001"(NNFTRI report, 2005). 
In spite of implementing iron supplementation and nutrition education, as well 
as public health measures through the Primary Health Care (PHC) system, Iron 
deficiency and its anemia is still one of the most common nutritional problems in 
Islamic republic of Iran. So, implementing an appropriate intervention for 
combating this public health problem of the country has been regarded as a 
priority of Iran's Ministry of Health & Medical Education (MOH&ME). In order to 
find a suitable, scientific and feasible solution and also to use other countries' 
experiences, an international workshop was held on this issue in Iran in 1996 
(WHO/EMRO report, 1996). At the end of the workshop, some 
recommendations and solutions were presented to overcome the problem. One 
of the most important suggested solutions was food fortification strategy. 
Fortification of food with micronutrients is a valid technology for reducing 
micronutrient deficiency as part of a food-based approach whenever and 
wherever existing food supplies fail to provide adequate levels of certain 
nutrients in the diet. In such circumstances, food fortification reinforces and 
supports ongoing nutrition improvement programs and should be regarded as 
part of a broader, integrated approach to prevent micronutrient malnutrition. 
Fortification of foods with micronutrients is a technologically, programmatically, 
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and economically effective method of increasing micronutrients intake in 
populations (Nestel and Nalubola, 2000) (Lotfi, 2002) (Darnton-Hill and 
Nalubola, 2002).  
It is suggested that food fortification might be an inexpensive, simple, and 
effective way of controlling and preventing iron deficiency and its related anemia 
in many countries (Allen et al, 2006). Since iron deficiency is one of the main 
public problems in Iran, Ministry of Health and Medical Education (MOH&ME) 
started technical studies on this subject. So, based on dietary information 
indicating that bread (Mean consumption in Iran 320gr/day) is an ideal vehicle 
for a fortification program in Iran, a pilot study of flour fortification with 30 mg/kg 
iron and 1.5 mg/kg folic acid was conducted in Bushehr province, in 2000. This 
intervention was conducted to evaluate its possible problems and capacities for 
extending it to a national level.  In this way, the program gradually progressed 
and in 2008, national flour fortification was started as a mandatory program in 
the country. In all flour fortification programs, a mixture of micronutrients 
(Premix) is added to food with a special instrument (Microfeeder). In Iran, 
premix is produced inside the country and includes 42% ferrous sulphate, 
0.75% folic acid, and 57.25% Maize starch. The additional rate is 200gr/MT. 
Despite the advantages of this program, questions were raised by some 
nutritionists of steering committees and faculties from the beginning of the 
intervention about potential hazards of adding iron to flour for those who do not 
suffer from anaemia or iron deficiency. There were many reasons for their 
concern, which are summarized as follows: 
1. Considering the natural amount of iron in flour, and also added iron 
through fortification (30 mg/kg as ferrous sulphate), the total amount of 
iron of flour after fortification is about 40-80 mg/kg. This amount of iron is 
about two times more than what we expect from the fortification program.  
 
2. There is a wide range of daily intake of iron in the community. As the 
National Food Consumption Survey showed, the variety of iron intake 
among different age and sex groups in the country is from 3.6 to 68.9 
mg/day (NNFTRI report, 2005).  
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3. Even in developing countries, parts of the community with moderate and 
high socio-economical background have an adequate or high intake of 
heme iron that is easily absorbed and also can interfere with the 
absorption of non-heme iron in the diet. This can lead to iron overload or 
other kinds of related problems (Schuemann, 2001). 
Moreover, determining the tolerable upper intake level of iron is difficult, partly 
because of the fact that absorption of heme iron is much higher than non-heme 
iron and also the bioavailability of non-heme iron varies and can be influenced 
by different dietary factors. 
However, Iron is crucially important for normal functioning of the human body; 
both iron overload and iron deficiency lead to severe diseases (Swanson, 
2003). Iron overload is less common than iron deficiency, but can result in 
serious medical problems (Burke et al, 2001). 
Absorption of iron in the body is a well controlled process. In iron deficiency 
homeostatic mechanisms increase intestinal iron absorption, but its down-
regulation at high intake levels seems insufficient to prevent accumulation of 
high iron stores (Salonen et al, 1993) (Swanson, 2003). Moreover, iron is known 
to catalyze the generation of hydroxyl radicals from super oxide anions and to 
increase oxidative stress which in turn increases free iron concentration (Fang 
et al, 2002). Meanwhile, some animal experiments showed the negative effects 
of iron overload and oxidative damages (Knuston et al, 2000) (Day et al, 2003); 
However, the relevance of these studies to humans is unknown. Unfortunately, 
there are not enough human studies about the effects of high iron intake on 
oxidative damages to help us to make the right decision (Binkoski et al, 2004). 
So, in fortification programs with iron, concerns exist regarding iron over load in 
some parts of the community that are not anemic. 
Today, the problems of oxidative stress and the effects of their incidence have 
been highly addressed by the scientific community. This is justified by the fact 
that oxidative stress plays an important role in the pathogenesis of many 
noncommunicable diseases and cellular defects that lead to specific diseases  
(Salonen et al, 1993) (Kurtoglu et al, 2003) (Sareen et al, 2003). So, despite the 
fact that Iran's flour fortification program just provides about 40% of the average 
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daily needs of the several population (based on the results of national food 
consumption survey, iron daily needs is 19 mg), and could not be dangerous 
even for non-anemic members of the community, regarding the importance of 
issue and the high number of non anemic population, this research was design. 
The aim of this research was to study the effects of flour fortification program on 
oxidative stress biomarkers and Iron status of non-anemic individuals, during 
two time periods (32 and 64 weeks ). It should be noted that we could not find a 
similar study in the ltrature. 
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2 GOAL AND OBJECTIVES  
2-1 Goal  
The goal of this study was to investigate the effect of consuming fortified flour 
with iron, on oxidative stress biomarkers and iron status of non- anemic, 
apparently healthy, 40- to 65-year-old adults.  
This study had two parts; the first part was a randomized field trial, and the 
second one was a before and after study. 
2-2 Objectives 
2-2-1Objectives of the First Part of the Study (Randomized Field Trial): 
1- Determining the effect of consuming fortified flour with iron on iron status 
including hemoglobin, ferritin, serum iron, total iron binding capacity, transferrin 
saturation, and serum transferrin receptor of 40- to 65-year-old males and 
females in the case group, and comparing it with the control group at baseline 
and after 32 weeks.  
2- Determining the mean values of oxidative stress biomarkers including total 
anti-oxidant capacity (TAC), malonedialdehyde (MDA), glutathione peroxidase 
(GPx), super-oxide dismutase (SOD), protein carbonyl (PC), and oxidized LDL 
of 40-65 years old males and females in case group and comparing it with the 
control group at baseline and after 32 weeks.  
3- Determining daily intake of Iron, antioxidant vitamins (Vitamin A, C, E, and 
carotenoids) and other related biochemical parameters (albumin, total protein, 
and uric acid) in 40- to 65-year-old males and females in the case group and 
comparing it with the control group at baseline and after 32 weeks. 
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2-2-2 Objectives of the Second Part of the Study (Before and After Study): 
1- Determining and comparing the effect of consuming fortified flour with iron on 
iron status of 40- to 65-year-old males and females at baseline and after 32 and 
64 weeks in Semnan.  
2- Determining and comparing the mean values of oxidative stress biomarkers 
of 40- to 65-year-old males and females at baseline and after 32 and 64 weeks 
in Semnan.  
3- Determining daily intake of Iron, antioxidant vitamins and other related 
biochemical parameters in 40- to 65-year-old males and females at baseline, 
after 32 and 64 weeks in Semnan   
 2-3 Practical Objectives 
The results of this study can help policy makers in designing future interventions 
based on food fortification in the country. 
 
2-4 Impact  
Enhancing health status in the community 
 
2-5 Hypothesis of the Survey 
1- Consuming Iron fortified flour does not cause iron overload in the study 
population after 32 and 64 weeks  
2- Consuming Iron fortified flour does not induce oxidative stress biomarkers in 
the study population after 32 and 64 weeks 
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3 LITERATURE REVIEW 
3-1 Micronutrient Deficiency 
3-1-1 Micronutrient Deficiency in the World  
Vitamins and minerals, often called micronutrients, are essential for human 
physical and mental health and survival. Only very small quantities of them are 
needed, but deficiencies can have disproportionately large, often life-
threatening, effects (Verster, 2004). Yet deficiencies of many important 
vitamins, such as vitamin A and D, and minerals such as iron, zinc and iodine 
are widespread in many parts of the world (Verster, 1996). More than 2 billion 
people in the world today, nearly all of them in developing countries, suffer from 
nutritional deficiencies, mainly the lack of micronutrients such as iron, vitamin A, 
iodine and folic acid (World Health Report, 2002).  
Iron deficiency (ID) is the most common micronutrient deficiency. The most 
commonly affected populations in developing countries are pregnant women, 
school-age children, non-pregnant women, and preschool children; as many as 
50% of the elderly and adult males can be anemic as well. Factors other than ID 
that cause anemia include deficiencies of nutrients such as B12, folic acid, B6, 
riboflavin, vitamin A, and general infections and chronic diseases such as 
HIV/AIDS.  Anemia has important health and economic consequences. A study 
of 15 countries showed that the median value of productivity losses due to ID 
was about USD 4/person/year or 0.9% gross domestic product (GDP), and this 
excluded the lowered effectiveness of money spent on education (World Bank, 
1994). The World Bank has estimated that interventions to end micronutrient 
malnutrition were among the most cost-effective investments in the health 
sector. Failure to act in a country where micronutrient malnutrition exists can 
waste as much as 2-3% of the gross domestic product (GDP) (UNICEF, 2003), 
whereas acting to solve the problem comprehensively and sustainably would 
cost less than 0.3% of GDP.  
In Iran, iron-deficiency anemia is one of the most common nutritional problems. 
A national survey  conducted by the Ministry of Health and Medical Education 
and UNICEF in 1999 showed that 33.4% of the Iranian women were anemic 
according to hemoglobin levels, and 34.5% were iron deficient according to 
8 
 
serum ferritin levels. More than 38% of 15- to 23-month-old children were 
anemic as well. Among adolescents, data showed that the prevalence of 
anemia in different provinces was from 11% to 36 %. Iron deficiency is 
considered to be more common among adolescent girls than boys (MOH&ME, 
2003).  
Based on these findings, in Iran, it seems that iron deficiency and the resultant 
anemia are important nutritional problems. 
 
3-1-2 Major Issues in Controlling Iron Deficiency 
There are four main strategies for combating iron deficiency: food 
diversification, supplementation, food fortification, and public health measures 
(e.g. controlling parasitic infestations). In other words, iron status may be 
improved through food-based strategies (food diversification and food 
fortification) and nonfood-based strategies (supplementation and controlling 
parasitic diseases):  
3-1-2-1 Food Diversification 
Increasing dietary diversity means increasing both the quantity and the range of 
micronutrient-rich foods consumed. In practice, this requires the implementation 
of programs that improve the availability and consumption of, and access to, 
different types of micronutrient-rich foods (such as animal products, fruits and 
vegetables) in adequate quantities, especially among those who at risk for, or 
vulnerable to, micronutrient malnutrition (MNM). In poorer communities, 
attention also needs to be paid to ensuring that dietary intakes of oils and fats 
are adequate for enhancing the absorption of the limited supplies of 
micronutrients. Increasing dietary diversity is the preferred way of improving the 
nutrition of a population because it has the potential to improve the intake of 
many food constituents – not just micronutrients – simultaneously (Allen et al, 
2006). Ongoing research suggests that micronutrient-rich foods also provide a 
range of antioxidants and probiotic substances that are important for protection 
against selected noncommunicable diseases and for enhancing immune 
function. However, as a strategy for combating MNM, increasing dietary 
diversity is not without its limitations, the main one being the need for behavior 
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change and for education about how certain foods provide essential 
micronutrients and other nutritive substances. A lack of resources for producing 
and purchasing higher quality foods can sometimes present a barrier to 
achieving greater dietary diversity, especially in the case of poorer populations. 
 
3-1-2-2 Supplementation  
Supplementation is the term used to describe the provision of relatively large 
doses of micronutrients, usually in the form of pills, capsules or syrups. It has 
the advantage of being capable of supplying an optimal amount of a specific 
nutrient or nutrients, in a highly absorbable form, and is often the fastest way to 
control deficiency in individuals or population groups that have been identified 
as being deficient. 
In developing countries, supplementation programs have been widely used to 
provide iron and folic acid to pregnant women, and vitamin A to infants, children 
under 5 years of age and postpartum women. Because a single high-dose 
vitamin A supplement improves vitamin A stores for about 4–6 months, 
supplementation two or three times a year is usually adequate. However, in the 
case of the more water-soluble vitamins and minerals, supplements need to be 
consumed more frequently. Supplementation usually requires the procurement 
and purchase of micronutrients in a relatively expensive pre-packaged form, an 
effective distribution system and a high degree of consumer compliance 
(especially if supplements need to be consumed on a long-term basis). A lack of 
supplies and poor compliance are consistently reported by many 
supplementation program managers as being the main barriers to success 
(Allen et al, 2006). 
 
3-1-2-3 Public Health Measures 
In addition to the specific interventions outlined above, public health measures 
of a more general nature are often required to help prevent and correct MNM, 
because it is often associated with poor overall nutritional status and with a high 
prevalence of infection. Such measures include infection control (e.g. 
immunization, malaria and parasite control), and improvement of water and 
sanitation. Other factors, such as the quality of child care and maternal 
10 
 
education, also need to be taken into consideration when developing public 
health responses to MNM.  
 
3-1-2-4 Food Fortification 
Food fortification refers to the addition of micronutrients to processed foods. In 
many situations, this strategy can lead to relatively rapid improvements in the 
micronutrient status of a population, and at a very reasonable cost, especially if 
advantage can be taken of existing technology and local distribution networks. 
Since the benefits are potentially large, food fortification can be a very cost-
effective public health intervention. However, an obvious requirement is that the 
fortified food(s) needs to be consumed in adequate amounts by a large 
proportion of the target individuals in a population. It is also necessary to have 
access to, and to use, fortificants that are well absorbed yet do not affect the 
sensory properties of foods. In most cases, it is preferable to use food vehicles 
that are centrally processed, and to have the support of the food industry 
(Hertrampf, 2002). 
Fortification of food with micronutrients is a valid technology for reducing 
micronutrient malnutrition as part of a food-based approach when and where 
existing food supplies and limited access fail to provide adequate levels of the 
respective nutrients in the diet. In such cases, food fortification reinforces and 
supports ongoing nutrition improvement programs and should be regarded as 
part of a broader, integrated approach to prevent MNM, thereby complementing 
other approaches to improve micronutrient status (Verster, 2004). 
In spite of implementing iron supplementation and nutrition education as well as 
public health measures through PHC system, Iron deficiency and its anemia is 
still one of the most common nutritional problems in Islamic republic of Iran. The 
extent and severity of anemia and iron deficiency, as well as health and 
economic consequences, highlight the need for prompt and efficient 
interventions. The food fortification program, which was a new approach, is 
being implemented in different countries and has become an integral part of the 
governments' overall economic development plan and has gained a key 
position in national health priorities.  
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 In Iran, grains provide 63% of the total energy intake, and consumption of 
bread ranges from 230 to 505 gr/person/day (mean consumption of bread in 
Iran is 320 gr/person/day) (Sadighi et al, 2008). This dietary information 
indicates that wheat flour is an ideal vehicle for a fortification program in Iran. 
 
3-1-3 Advantages and Limitations of Food Fortification 
Food fortification offers a number of advantages but has also some limitations. 
These advantages and limitations are summarized as follows: 
 
3-1-3-1 Advantages of Food Fortification 
Being a food-based approach, food fortification offers a number of advantages 
over other interventions aimed at preventing and controlling micronutrient 
deficiency (World bank, 1994) (Allen et al, 2006). These include: 
• If consumed on a regular and frequent basis, fortified foods will maintain 
body stores of nutrients more efficiently and more effectively than will 
intermittent supplements. Fortified foods are also better at lowering the 
risk of the multiple deficiencies that can result from seasonal deficits in 
the food supply or a poor quality diet. 
• Fortification of widely distributed and widely consumed foods has the 
potential to improve the nutritional status of a large proportion of the 
population, both poor and wealthy. 
• Fortification requires neither changes in existing food patterns – which 
are notoriously difficult to achieve, especially in the short-term – nor 
individual compliance. 
• In most settings, the delivery system for fortified foods is already in place, 
generally through the private sector. 
• In most cases, it is feasible to fortify foods with several micronutrients 
simultaneously. 
• When properly regulated, fortification carries a minimal risk of chronic 
toxicity. 
• Fortification is often more cost-effective than other strategies, especially 
if the technology already exists and if an appropriate food distribution 
system is in place. 
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3-1-3-2 limitations of food fortification 
Although it is generally recognized that food fortification can have an enormous 
positive impact on public health, there are, however, some limitations to this 
strategy which are summarized as follows: 
• A specific fortified foodstuff might not be consumed by all members of a 
target population. Conversely, everyone in the population is exposed to 
increased levels of micronutrients in food, irrespective of whether or not 
they will benefit from fortification. 
• Infants and young children, who consume relatively small amounts of 
food, are less likely to be able to obtain their recommended intakes of all 
micronutrients from universally fortified staples or condiments alone; 
fortified complementary foods may be appropriate for these age groups. 
It is also likely that in many locations fortified foods will not supply 
adequate amounts of some micronutrients, such as iron for pregnant 
women, in which case supplements will still be needed to satisfy the 
requirements of selected population groups. 
• Fortified foods often fail to reach the poorest segments of the general 
population who are at the greatest risk of micronutrient deficiency. This is 
because such groups often have restricted access to fortified foods due 
to low purchasing power and an underdeveloped distribution channel. 
• While it is generally possible to add a mixture of vitamins and minerals to 
relatively inert and dry foods, such as cereals, interactions can occur 
between fortificant nutrients that adversely affect the organoleptic 
qualities of the food or the stability of the nutrients. 
To ensure their success and sustainability, food fortification programs should be 
implemented in concert with poverty reduction programs and other agricultural, 
health, education and social intervention programs. Food fortification should 
thus be viewed as a complementary strategy for improving micronutrient status 
(Allen et al, 2006), (Verster, 1996). 
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3-1-4 Flour Fortification with Iron 
Nutrient supplementation of foods was mentioned first in the year 400 B.C. by 
the Persian physician Melanpus, who suggested adding iron filings to wine to 
increase soldiers’ potency. However, it was not a real supplementation and was 
more similar to fortification (Mejia, 1994).  
Flour fortification with vitamin B1, niacin, and iron became possible in the USA 
in 1938. During the Second World War, flour fortification was introduced in the 
United Kingdom, too. There are now numerous countries in which flour 
producers are obliged by law to fortify their products with certain vitamins and 
minerals. Many other countries practice specific flour fortification on a voluntary 
basis (Allen et al, 2006).  
3-1-4-1 Flour Fortification with Iron in Iran 
In Iran there has been a formal nutrition strategy since 1994, and the reduction 
of iron deficiency anemia is part of it. Food fortification is one component of the 
nutrition strategy. 
In 1996, flour fortification was conducted on a small scale in one of the districts 
of Isfahan (a province in the central of Iran) with 1200 population. The results 
showed an increase in hemoglobin in the target population. Based on the 
success of this activity and iron deficiency in Iran, The Iranian Ministry of Health 
and Medical Education launched a program for fortifying flour with iron on 31 
May 2001 in Bushehr province, where the population was 800,000 (Sadighi et 
al, 2008). This province was selected due to a high prevalence of iron 
deficiency and anemia among women of child-bearing age (50% IDA according 
to a 1996 survey). Also, the province has an efficient health management 
system, a high level of commitment, as well as a strong primary health care 
network. Another conducive factor was the existing quality control labs for 
monitoring the amount of iron in the fortified flour. All the flour consumed was 
produced in two large-scale mills. Together they produced about 360 tons of 
fortified flour, which was sufficient for the daily needs of the population. 
All requirements for the fortification process, equipment, quality assurance, and 
legislation have been met. 
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Flour is a good vehicle for fortification in Iran because: 
• Wheat is a strategic product in Iran and all its purchasing, storage, 
processing, and distributing process is under governmental control. 
• Bread is a strategic food for the Iranian population culturally and 
controlling its price, especially for low income households, is considered 
as one of the government's key strategies which is known as subsidy. 
• According to National Household Food Consumption Survey, bread is a 
staple food and its consumption trend is predictable. 
• International experiences suggest that iron as ferrous sulphate is stable 
and it does not change the color and taste of flour with the shelf life of 
less than two months. 
• The main distributor of flour is the government. 
• Iron fortification is feasible and economic for local flour industry. 
• Flour fortification with multi-micronutrient is also possible and 
economical.  
The advantages of flour such as long shelf life, excellent baking properties and 
easy digestibility ensures its success. Fortifying wheat flour with iron, make it 
possible to provide a special amount of additional iron to the diet of women, and 
indeed the entire population.  
 
3-1-4-2 Evaluation of the Flour Fortification Program in Iran 
 
In order to evaluate four fortification program in Iran three evaluations have 
been done in 2004, 2007, and 2009. The first study (conducted in 2004) was a 
field trial to evaluate program effectiveness. The intervention province 
(Bushehr) was compared with a control province (Fars) for anemia and iron-
deficiency indicators. The target population was women aged 15-49 years and 
men aged 40-60 years. In this first evaluation, women in the intervention 
province (Bushehr) had a lower prevalence of low ferritin levels compared with 
women in the control province. Women from the two provinces did not differ in 
terms of hemoglobin levels or iron-deficiency anemia, and men from the two 
provinces did not differ significantly with regard to any of the tested parameters. 
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Importantly, although the flour fortification had no beneficial effect on 
anemia/iron deficiency in men, the iron fortification program also did not have 
the adverse effects on men, namely increased hemoglobin and ferritin levels. 
These findings suggested that the iron fortification program in Iran had a 
beneficial effect, but only on ferritin indicators among women. 
This type of field trial study design could not be used for the second and third 
evaluations, as the flour fortification program had been expanded into other 
provinces (including Fars province) by the time the later studies were 
conducted. Therefore, the second and third evaluations were designed as 
before-and-after studies. The second evaluation (2007) showed that women 
and men in Bushehr province had a lower prevalence of low ferritin levels 
compared with the baseline (pre-intervention) sample.  
In 2008, the World Bank suggested that parallel evaluations should be 
conducted in Bushehr and Golestan provinces. Therefore, another study was 
conducted in 2009, to evaluate the effectiveness and process of flour 
fortification with iron and folic acid in these two Iranian provinces. This study 
constitutes the third evaluation in Bushehr province and the first evaluation in 
Golestan province. This study showed that the program of wheat flour 
fortification with iron in Iran has had a beneficial effect on only the prevalence of 
iron deficiency in the studied women.  
It is believed that some of the important factors diminish the beneficial effects of 
flour fortification on anemia in Iran include parasitic and infectious diseases, and 
other diseases prevalent in these areas (e.g. minor thalassemias). The 
relatively low availability of other micronutrients (e.g., vitamin A) should not be 
ignored. 
In summary, we have shown that the flour fortification program in Iran is a 
useful component of a public health strategy aimed at improving iron deficiency 
status. However, in areas where anemia is not mainly due to iron deficiency, an 
iron fortification program might decrease the prevalence of iron deficiency 
without affecting the prevalence of anemia. 
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3-2 Iron and its Role in Human Health 
 
3-2-1 Iron Absorption and Storage 
Iron, by far the most abundant transition metal in the body, is an essential 
element for the utilization of oxygen, as well as a component of numerous 
oxidases and oxygenases. The major difficulty to overcome in iron assimilation 
by living cells is its bioavailability (Puntarulo, 2005).  Soluble Fe (II) is readily 
oxidized in aqueous solutions to the essentially insoluble ferric hydroxide. In 
normal adults who ingest a diet free of iron supplements, the body content of 3-
5 g is fairly well balanced among functional compounds, storage complexes, 
transport chelates, and ingestion and excretion.  
Iron is transported and stored in specific proteins such as transferrin, lactoferrin, 
ferritin, and heme proteins. Serum transferrin is a carrier of iron in the blood that 
binds two Fe (III) ions with a high affinity. Under physiological conditions, only 
30% of transferrin is saturated with iron (Pantopoulos and Hentze, 2000). Ferric 
iron is reduced to ferrous iron and delivered from the endosome into the cytosol. 
Excess iron is sequestered in ferritin, which is the main intracellular iron storage 
protein. Ferritin is composed of 24 subunits of H- and L-chains and can store up 
to 4500 atoms of Fe/molecule (Ponka et al, 1998).  
The main part of body iron (60-70%) is utilized within hemoglobin in circulating 
red blood cells (Andrews, 2000). Other iron-reach organs are the liver and 
muscles. About 20-30% of body iron is stored in hepatocytes and in 
reticuloendothelial macrophages, to a large extent within ferritin and its 
degradation product hemosiderin. The remaining iron in body primarily exists in 
myoglobin, cytochromes, and iron containing enzymes. A healthy adult absorbs 
1-2 mg of iron from the diet daily, which compensates for nonspecific iron 
losses by cell desquamation in the skin and the intestine. In addition, 
menstruating women physiologically lose iron through bleeding. Erythropoiesis 
requires approximately 30 mg iron/day, which is mainly provided through 
recycling iron via reticuloendothelial macrophages that ingest senescent red 
blood cells and release iron to circulating transferrin (Aisen et al, 2001). An 
average daily Iranian diet approximately contains 15 mg of iron (11.5 – 17.6), 
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from which less than 1-2 mg is absorbed (NNFTRI, 2005). In Iran, there is no 
data available on the bioavailability of nutrients, especially iron. 
 
3-2-2 Biological Function of Iron 
 Despite the fact that iron is the second most abundant metal in the earth's crust 
, iron deficiency is the world's most common cause of anemia. When it comes to 
life, iron is more precious than gold. Iron absorption is the sole mechanism by 
which iron stores are physiologically manipulated. Iron is an essential nutrient 
for normal cellular functions and has the capacity to form a variety of 
coordination complexes with organic ligands in a dynamic and flexible mode 
(Papanikolaou and Pantopoulos, 2005). Iron exists in two oxidative states, 
ferrous, Fe (II), and ferric, Fe (III), which can donate or accept electrons. 
Although these redox reactions are important for biological reactions, they can 
also be hazardous to cells. This makes it a useful component of cytochromes, 
oxygen-binding molecules and some enzymes. However, excess of iron can 
potentially generate oxidative stress via increasing the production of reactive 
oxygen species (ROS). Redox reaction involving iron plays a key role in the 
formation of harmful free radicals and ROS that damage living cells via various 
pathways (Yamaji et al, 2004). Overproduction of ROS can damage different 
biomolecules and, consequently, can contribute to the initiation and 
development of several chronic pathologies such as diabetes, cancer, and 
cardiovascular diseases (Fraga and Oteiza, 2002) (Puntarulo, 2005). 
 
3-2-3 Mechanism of Iron Toxicity  
 
Iron is a critical element required for the normal functioning of all body cells, and 
is necessary for basic metabolic processes such as oxygen transport, DNA 
synthesis, cytochromes P450 enzyme oxidative metabolism and electron 
transport. Iron induces damage through nontransferrin iron in plasma. 
One of the reasons iron is so ubiquitous in biology is its facility to redox cycle 
between the Fe2 and Fe3 state. In this process, it can generate free radicals, 
particularly in iron overload. The hydroxyl radical is the radical which has been 
most closely associated with iron-induced toxicity. There are probably other 
species which are important, such as the peroxynitrite (Puntarulo, 2005). Iron's 
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toxicity is largely based on Fenton and Haber-Weiss chemistry  (Figure 1.), 
where catalytic amounts of iron are sufficient to yield hydroxyl radicals (OH°) 
from superoxide (O2°-) and hydrogen peroxide (H2O2), collectively known as 
ROS (Papanikolaou and Pantopoulos, 2005). 
 
 
 
Figure 1. Fenton and Haber-Weiss reaction 
 
Fe (II) + H2O2  Fe (III) + OH-  + OH (Fenton) 
 
Fe (III) + O2°- Fe (II) + O2 
 
Net reaction:  
 
                         Fe 
H2O2 + O2°-  OH-  + OH°+O2   (Haber-Weiss) 
 
 
As a matter of fact, ROS are inevitable byproducts of aerobic respiration and 
emerge as a result of incomplete reduction of dioxygen in mitochondria. ROS 
can also be generated during enzymatic reactions in other sub cellular 
compartments, such as in peroxisomes, endoplasmic reticulum, or the 
cytoplasm and are also produced by the membrane-bound NADPH oxidase 
complex, a multisubunit enzyme primarily expressed in phagocytic neutrophils 
and macrophages (Hampton et al, 1998). Finally, ferrous iron can also 
contribute as a reactant, rather than as a catalyst, to free radical generation 
through direct interaction with oxygen, via ferryl (Fe2+-O) or perferryl (Fe2+-O2) 
iron intermediates (Figure. 2). 
 
Figure 2. Direct interaction of iron with oxygen 
Fe (II) + H2O2  Fe (II)-O + H2O 
Fe (II) + O2                   [Fe (II)-O2              Fe (III)-O2°- ]               Fe (III) + O2°-- 
 
It has been proposed that when [O2]/ [H2O2]> 100, these reactions may 
represent an important source for free radical generation in vivo (Huang, 2002). 
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In fact, free iron can cause cell damage by catalyzing the conversion of 
superoxide and hydrogen peroxide to free radical species that attack cellular 
membranes, proteins and DNA (Drog, 2002) (Fang et al, 2002). Free radicals 
are highly reactive species and may promote oxidation of proteins, peroxidation 
of membrane lipids, and modification of nucleic acids. An increase in the steady 
state levels of reactive oxygen (or nitrogen) species beyond the antioxidant 
capacity of the organism, called oxidative stress (or nitrosative stress), is 
encountered in many pathological conditions, such as chronic inflammation, 
ischemia-reperfusion injury, or neurodegeneration (Ischiropoulos and Beckman, 
2003). 
3-3 Oxidative Stress 
3-3-1 Oxidative Stress Definition 
Oxidative stress (OS) is an imbalance between free radicals and reactive 
oxygen species (ROS) and protective radical scavenging antioxidants (AOX) 
resulting from either an overproduction of ROS or a deficit in AOX protection 
(Terada 2006). Oxidative Stress (OS) is also used to describe the steady state 
level of oxidative damage in a cell, tissue, or organ, caused by the reactive 
oxygen species (ROS). This damage can affect a specific molecule or the entire 
organism. Reactive oxygen species, such as free radicals and peroxides, 
represent a class of molecules that are derived from the metabolism of oxygen 
and exist inherently in all aerobic organisms. Atmospheric oxygen in its ground-
state is distinctive among the gaseous elements because it is a biradical, or in 
other words it has two unpaired electrons. This feature makes oxygen 
paramagnetic. It also makes oxygen very unlikely to participate in reactions with 
organic molecules unless it is "activated". The requirement for activation occurs 
because the two unpaired electrons in oxygen have parallel spins. According to 
Pauli's exclusion principle, this precludes reactions with a divalent reductant, 
unless this reductant also has two unpaired electrons with parallel spin opposite 
to that of the oxygen, which is a very rare occurrence. Hence, oxygen is usually 
non-reactive to organic molecules which have paired electrons with opposite 
spins. This spin restriction means that the most common mechanisms of 
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oxygen reduction in biochemical reactions are those involving transfer of only a 
single electron.  
Activation of oxygen may occur by two different mechanisms: absorption of 
sufficient energy to reverse the spin on one of the unpaired electrons, or 
monovalent reduction. The biradical form of oxygen is in a triplet ground state 
because the electrons have parallel spins. If triplet oxygen absorbs sufficient 
energy to reverse the spin of one of its unpaired electrons, it will form the singlet 
state, in which the two electrons have opposite spins (Fig. 3). This activation 
overcomes the spin restriction and singlet oxygen can consequently participate 
in reactions involving the simultaneous transfer of two electrons (divalent 
reduction). Since paired electrons are common in organic molecules, singlet 
oxygen is much more reactive towards organic molecules than its triplet 
counterpart (Fang et al, 2002). The nomenclature of the various forms of 
oxygen is shown in Figure 3. The second mechanism of activation is by the 
stepwise monovalent reduction of oxygen to form superoxide (O 2), hydrogen 
peroxide (H2O2), hydroxyl radical (OH) and finally water according to the 
scheme shown in Figure 4. The first step in the reduction of oxygen forming 
superoxide is endothermic but subsequent reductions are exothermic (Gilbert, 
2000). 
Examples of oxygen free radicals are superoxide, hydroxyl, peroxyl, alkoxyl, 
and hydroperoxyl radicals.  
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Figure 3: Nomenclature of the various forms of oxygen 
 
The activation states of oxygen are shown in figure 4. The first step in the 
reduction of oxygen forming superoxide is endothermic but subsequent 
reductions are exothermic (Gilbert, 2000). 
 
Figure 4: The activation states of oxygen 
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3-3-2 Oxidative Stress Sources 
There are several sources by which the reactive oxygen species and free 
radical are generated. Most reactive oxygen species come from the 
endogenous sources as by-products of normal and essential metabolic 
reactions, such as energy generation from mitochondria or detoxification 
reactions involving the liver cytochromes P-450 enzyme system (Kurz et al, 
2007). Exogenous sources include exposure to cigarette smoke, environmental 
pollutants such as emissions from automobiles and industries, consumption of 
alcohol in excess, asbestos, exposure to ionizing radiation, and bacterial, fungal 
or viral infections. The determinants of oxidative stress are regulated by an 
individual's unique hereditary factors, as well as his/her environment and 
characteristic lifestyle. Unfortunately, under the present day life-style conditions 
many people run an abnormally high level of oxidative stress that could 
increase the probability of an early decline in optimum body functions. 
 
3-3-3 Oxidative Stress Measurement 
Many methods for the measurement of OS have been proposed and several 
reviews have been written (Morrow et al, 1992), (Spiteller & Spiteller 1997), 
(Davies et al, 1999), (Pratico et al, 2004). However, there is no current 
consensus on the best method in terms of being the most useful, reliable, 
accurate or specific for different types of oxidative insults (Pryor 1999) (Collins 
et al, 2004). 
In view of the lack of a "gold standard" method to assess free radical activity, 
three major approaches have been used: 1) determination of endogenous 
antioxidant levels; 2) measurement of the products of oxidized macromolecules; 
3) direct detection of free radicals. For assessing endogenous antioxidant 
capacity, most studies have examined the concentrations of antioxidants (such 
as vitamin E, vitamin C, carotenoids, folate, GSH, and zinc) in plasma and cells 
and the cellular activities of antioxidant enzymes (such as glutathione 
reductase, SOD, catalase, and glutathione peroxidase) (Fang et al, 2002). 
Assessment of lipid peroxidation for evaluating oxidized macromolecules 
includes the analysis of lipid peroxides, isoprostanes, diene conjugates, and 
breakdown products of lipids. Among these products, Malondialdehyde is often 
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used as a reliable marker of lipid peroxidation. For assessing ROS-induced 
protein oxidation, most investigators have evaluated the production of protein 
carbonyls, loss of free thiol groups in proteins, and nitration of protein-bound 
tyrosine residues (Fang et al, 2002). Now a days, urinary excretion of 8-
hydroxydeoxyguanosine may provide a useful, non-invasive means to assess 
whole-body DNA base oxidation in humans and animals (Jackson 1999). 
There are three non invasive approaches to the detection of free radicals; the 
optical method, electron paramagnetic resonance (EPR), and nuclear magnetic 
resonance (NMR). The most sensitive of these approaches is the optical 
method in which emission light emits from the tissue, either intrinsically or 
extrinsically with lucigenin as an amplifier (Okuda et al, 1992).   
    
3-3-4 Iron and Oxidative Stress 
Perhaps the most dramatic discovery in recent years concerning mechanisms 
of oxidative damage in biological systems has been the finding that superoxide 
anions (O2 • -) can release iron from ferritin, providing free iron to catalyse the 
peroxidation of cell membranes (Keyer and Imlay, 1996). Therefore, O2 • - 
causes an increase in the internal pool of free iron that may increase oxidative 
stress which, in turn, increases free iron concentration. Despite extensive 
literature on iron and lipid peroxidation, few studies have investigated the 
effects of iron fortified food consumption among non-anemic persons.  
 
3-4 Animal Studies 
The potential risks of an excess intake of iron in rats were first proposed over 50 
years ago (Richmond, 1959). The hypothesis that high iron intake may be 
related to an increased risk of colorectal cancer has been developed on the 
basis of epidemiological evidence showing an association between high meat 
intake and cancer of the colon and rectum. Bobbs (Bobbs, 1990) proposed that 
the presence of iron in the colon would act as a catalyst for the production of 
free radicals by bacteria. Previous animal studies investigating the colonic 
response to high dietary iron intake have shown that iron may act as a tumor 
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promoter, whereas phytate has been shown to be protective, an effect 
presumed to be due to its iron-binding capacity. Although Soyars and Fischer 
(Soyars and Fischer, 1998) showed that iron had no effects on cell proliferation 
or the development of aberrant crypt foci (ACF) in rats, Davis and Feng (Davis 
and Feng, 1999) showed an increase in ACF with iron fortification at levels as 
low as 140 mg/kg. The difference in the results of the two above-mentioned 
studies may be due to the difference in the sampling site, use of different strains 
of rats or the period of fortification used. 
The results of a study by Lund et al ( Lund et al, 2001) provided evidence that 
excess dietary iron, taken over an extended period, might pose a significantly 
greater level of oxidative stress to the mucosal cells of the colon and particularly 
to those lining the cecum, equivalent to the proximal colon in rats. This is the 
site suggested by epidemiological studies to be most vulnerable to excess iron 
intake. Whole-animal studies show that intravenous administration of iron 
dextran in rats also induces oxidative stress (Lim and Vaziri, 2004).  
In another animal study, the effects of parenterally administered 15 mg of iron 
dextran for 6 weeks on vascular oxidative stress were examined in mice. The 
results of this study showed that chronic parenteral administration of iron 
dextran markedly accelerated the thrombotic response to carotid artery injury, 
increased systemic and vascular ROS production, and impaired endothelium-
dependent vasorelaxation in mice. Recent studies suggest that iron plays a key 
role in apoptosis induced by a variety of insults (Carlini et al, 2006) (Roth and 
Garrick, 2003). Xu in his study strongly suggested that the age-related iron 
accumulation in muscle contributed to increased oxidative damage and 
sarcopenia, and that calorie restriction effectively attenuates these negative 
effects (Xu et al, 2008). However, some other studies such as the Krik’s study, 
found no difference in markers of oxidative damage between control and iron-
loaded mouse livers (Krik et al, 2001). The relevance of these animal studies to 
vascular diseases and thrombosis in humans is unknown, but these data 
suggest that iron overload may increase oxidative stress and thrombotic risk 
(Day et al, 2003). 
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3-5 Human Studies 
The effects of high dietary iron intake on oxidative stress have been particularly 
marked in women (Wurzelmann et al, 1996) (Kato, et al, 1999) (Isler et al, 2002) 
(Kurtoglu et al, 2003) (Amirkhizi et al, 2006), who are a more likely target group 
for iron supplementation. One study even showed that co-supplementation of 
ferrous salts with vitamin C exacerbates oxidative stress in the gastrointestinal 
tract (Fisher and Naughton, 2004). However, some studies have shown that 
iron supplementation is safe in anemic patients (Sareen et al, 2003) (Binkoski et 
al, 2004). One study suggested that iron and copper status might be associated 
with lipid peroxidation in subjects without metal overload (Arnaud et al, 2001). 
Recent results have led to the proposal that superoxide plays an additional role 
in oxidative stress, which is increasing the level of intracellular free iron ions 
(Garner, 1997) (Henle and linn, 1997). Another human study concluded that 
oxidative damage was much higher in elderly males, suggesting a gender 
difference related to hormonal factors (Fano et al, 2001).  
In one study, long-term alimentary iron overload resulted in a positive serum 
iron balance which, in turn, yielded an increased oxidative stress ( Rehema et 
al, 1998).In one cross-sectional study, plasma iron levels were positively 
associated with lipid peroxidation (lasheras et al, 2003). Also another study 
indicated that in breast cancer patients, higher concentrations of serum iron 
were significantly correlated with higher levels of MDA (Bae et al, 2009). 
A cohort study could not find any relationships between ferritin level and 
oxidative stress biomarkers (Senol et al, 2008). Furthermore, another study 
showed that ferritin played as a cytoprotective protein, minimizing oxygen free 
radical formation by sequestering intracellular iron (Orino et al, 2001).These 
results support other experimental studies ( in vivo and in vitro) reporting that 
iron may store along the negatively changed lipid bilayer and promote lipid 
peroxidation and subsequently membrane damage (Leake and Rankin, 1990). 
However, a great part of the discrepancy may be due to the variability in the 
methods used, the population analyzed, study outcomes or types of 
epidemiological design.  Results from a study on patients with acute myocardial 
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infarction showed an association between higher iron status and increased lipid 
peroxidation (Baykan et al, 2001).  
Excessive intake of iron may predispose to mammary carcinogenesis due to the 
fact that free iron works as a catalyst for ROS generation. However, study 
results on the relationship between dietary iron intake and breast cancer are not 
consistent. Epidemiological studies have reported that there is no association 
between dietary intake and breast cancer risk (Adzersen et al, 2003) (Kabat et 
al, 2007). A large scale study conducted on Chinese female breast cancer 
patients reported that the intake of heme iron increased the risk of breast 
cancer (Kallianpur et al, 2008). 
However with all the experimental evidence that ferrous iron promotes lipid 
peroxidation in vivo and in vitro (Heinecke et al, 1984) (Witztum, 1994) ( 
Adzersen et al, 2003) (Kabat et al, 2007), epidemiological literature on this 
association in humans is scarce and inconsistent (Salonen, 1993) (Iribarren et 
al, 1998) (Bae et al, 2009). The same controversy exists regarding the role of 
iron stores in atherogenesis, and we have found an equal number of studies 
suggesting a detrimental role for iron (Salonen et al, 1993) (Tuomainen et al, 
1998) (Liehr and Jones, 2001) (Kallianpur et al, 2008) as those suggesting a 
beneficial one (Sempos et al, 1994) (Orino et al, 2001) (Kirk et al, 2001).  
 
3-6 Antioxidant Defense System in Human Body 
Antioxidants are chemical compounds that inhibit oxidation (Halliwell, 2000). 
Some antioxidant defenses are as follows:  
• The enzymes that catalytically remove free radicals and other reactive 
species such as SOD, CAT, and peroxidase. We can include "thiol-
specific antioxidants" in this category as well. 
• Proteins such as transferrin, haptoglobins, and metallothionein that 
minimize the availability of pro-oxidants such as iron and copper ions. 
Coeruloplasmin that oxidizes ferrous ions also fits in this category.  
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• Proteins, such as heat shock proteins protect biomolecules against 
damage (including oxidative damage) through other mechanisms.  
• Low-molecular-mass agents scavenging ROS and RNS (including 
glutathione, ascorbic acid, α-tocopherol and uric acid) (Halliwell , 2000) 
The composition of antioxidant defenses differs from tissue to tissue and 
between cell types within a tissue. Extracellular fluids have different protective 
mechanisms from the intracellular environments. According to the place of 
action, the components of the antioxidative defense system can be divided as 
follows: 
Plasma antioxidant 
• Water soluble: vitamin C, albumin, uric acid, and coeruloplasmin 
• Lipid soluble: Vitamin E, carotenoids, and ubiquinol 
Cellular antioxidant  
• Water soluble: glutathione (GSH), vitamin C, SOD, CAT, GPx 
• Lipid soluble: Vitamin E, carotenoids, and ubiquinol 
Blood plasma albumin, urea, and bilirubin have proved to have substantial 
antioxidative properties (Mates et al, 2000).Blood plasma albumin, among its 
many other functions, serves as an important extra cellular antioxidant. Of extra 
cellular mainly blood plasma antioxidants, the role has been quite well 
described for bilirubin and urea. Urate binds iron and copper and scavenges 
hydroxyl radical, and peroxy radicals (Mates et al, 2000).   
 
  
 
 
 
 
28 
 
3-7 Overview 
A lack of consistency among many studies on iron intake and oxidative stress is 
related to different parameters that are assessed in different studies and the 
fact that iron fortification is accepted to be an effective strategy to control 
anemia which has given way to forgetting or neglecting its adverse effects. 
These studies should be developed and integrated into plans for monitoring 
populations after the introduction of iron flour fortification program. There are 
very few studies on oxidative stress effects of iron intake from flour fortification 
programs among non-anemic persons.  
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4 METHODOLOGY 
 
4-1 Study Design 
This study had a special design and was implemented in two different parts: a 
double blind field trial and a before and after study. 
Among 31 provinces of the Islamic Republic of Iran, Semnan province with a 
low prevalence of anaemia and iron deficiency was selected for this study. 
Then, two cities of this province were selected based on a number of criteria 
(each had to be equipped with a flour factory providing their flour needs, they 
had to neither import nor export flour, differences of geographical and socio-
economic indicators between them had to be as little as possible, and no flour 
fortification program was launched in these two cities prior to the study). 
Based on these qualifications, among the cities of this province, Damgan and 
Semnan were randomized as control and intervention cities, respectively.  in the 
first part of the study that was a field trial with a control group, after baseline 
data collection, flour fortification started only in the intervention city (Semnan) 
and all kinds of bread in that city were fortified; so, in this part of the study, we 
had an intervention city with a control city (Damgan) and we followed all 
participants from these two cities for 32 weeks.  
In the second part of the study, flour fortification started in Damgan as well. 
Since we could not keep this city as control in the second 32 weeks of the 
study, flour fortification was implemented both in Damgan and Semnan. This 
condition allowed us to follow fortification in Semnan for a longer period (64 
weeks) as the second part of our study. It should be noted that the same 
participants who took part in the first phase or baseline data collection also 
participated in the second and third phases and they were allowed to maintain 
their regular food habits. An overview of the study design is presented in Figure 
5. 
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Figure 5. An overview of study design 
 
 
31 
 
4-2 Sample Size 
Based on the results of a related survey (Amirkhizi et al., 2006) and the 
following equation below for two sided alternative:  
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The sample size needed for this study was 34 in each group and a total of 102 
volunteers for all.  
But based on the prevalence of Iron deficiency in this province, data gathering 
for three times, and possible cases of loss to follow-up, we selected 100 
persons in each group at baseline data collection. The samples were accessed 
based on a multi-stage stratified method by calling up their houses in a cluster 
manner. So, we had a total number of 400 volunteers in the first phase. 
  
4-3 Sampling Criteria 
Volunteers were recruited from among 40- to 65-year-old, non- anemic and 
apparently healthy men and women who lived in Semnan and Damgan 
(Semnan province) in 2007. The inclusion and exclusion criteria were as 
follows: 
Inclusion criteria: 
- Completing the letter of consent 
- Being apparently healthy 
- Being 40-65 years of age  
- Not following special diets for the last 2 months before the study 
- Not having any major organ system diseases 
- Not consuming any Iron or multivitamin supplements at least two months 
before the study 
- Not being pregnant and lactating 
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Exclusion criteria 
- Smoking 
- High blood pressure (systolic B.P. more than 140 mmHg or diastolic B.P. more 
than 90 mmHg)  
- Anemia (Hb≤12mg/dl for women, and Hb≤13mg/dl for men)  
- Moving out of their city for more than three months 
- Having undergone any kind surgical operation  
- Using iron or multivitamin supplements 
- Death 
Volunteers were selected if their complete blood count (CBC) was within the 
normal range and met the criteria of entering the study. The purpose and the 
nature of the study and what was expected from the subjects in terms of 
participation were explained to them and each volunteer signed a written 
consent prior to entering the study. The protocol of the study was approved by 
the Ethical Committee of National Nutrition and Food Technology Research 
Institute (NNFTRI), and Ministry of Health and Medical Education, Tehran, Iran. 
It should be noted that in the first phase of the study, those who suffered 
anaemia were referred to a physician for treatment. Volunteers could withdraw 
their participation at any time during the study. 
4-4 Data Collection 
Volunteers were asked to be present at the Health Care Center of the city in 
each phase of data collection. Based on our study design, we had three phases 
for data collection; at the beginning of the study (the first phase), at the end of 
the 32nd week (the second phase), and at the end of the 64th weeks (the third 
phase). Examination and interviewing (completing the information forms) were 
the methods of data collection. In each of the three phases, demographic, 
anthropometric, blood pressure, information on food intake (3-day 24-hour recall 
and a food frequency questionnaire with 103 items), physical activities (a short 
version of IPAQ), and some oxidative stress biomarkers were the main data that 
were collected (a copy of the study forms is available in the appendix section). 
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4-5 Anthropometric Measurements 
At all three phases of the study, anthropometric measurements of the 
volunteers were taken. Body weight was measured with 100 gr accuracy, using 
digital scales (Seca) with minimum clothing and without shoes. Height was 
measured with a non-stretchable tape (Seca) with 0.1 cm accuracy. Body mass 
index (BMI) was calculated using the equation; BMI=weight (kg)/height (m) 2 
and was recorded on a special information form.  
4-6 Dietary Assessment 
At all three phases of the study, a 3-days 24-hour recall and a Food Frequency 
Questionnaire with about 103 items (quantitative), which was validated by the 
Centre for Endocrinology and Metabolism Research of Shahead Beheshti 
University of Medical Sciences, Tehran, Iran (Fazeltabar et al, 2006) were taken 
from each volunteer by a trained nutritionist. Quantities were estimated from 
photographs of portion sizes and from household measures (Ghafarpour et al, 
2007). Volunteers were allowed to maintain their regular food habits. Data was 
translated into energy and nutrients (energy, micro and macronutrients) using 
Food Dorosti Processor (FDP) II software, which has been modified for Iranian 
foods. 
4-7 Laboratory measurements 
8-12 ml blood samples were drawn from the volunteers in the morning after 12-
14 hours of fasting at the three phases (baseline, after 32 weeks, and after 64 
weeks). Blood was taken from the median cubital vein and divided in two parts, 
either with or without anticoagulant, in acid washed tubes. About 1.5-2 ml was 
used to measure hemoglobin and cell blood count (CBC) in standard tubes 
containing anticoagulant. Sera from clot samples were recovered after 1 hour at 
room temperature (RT) followed by centrifugation at 2500g at RT for 20 
minutes. In order to avoid repeated serum defrosting, we divided all our lab 
tests in six parts, so serum samples were divided in six parts and stored at -
80°C awaiting further analysis. 
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The serum samples were analyzed for: 
Dependent variables Methods 
Hemoglobin Cell counter 
Ferritin immunoturibidimetric 
Serum Iron Ferene (colorimetric) 
TIBC Immunoturibidimetric  
[Transferrin mg/dl X 1.25] 
Transferrin immunoturibidimetric 
STfR Elisa 
MDA Spectrophotometric 
TAC Colorimetric 
SOD Elisa 
GPx Elisa 
Oxidized-LDL Elisa 
PC Elisa 
Albumin Bromocresol green 
Uric acid Colorimetric (Toos) 
Total protein Biuret 
Total Bilirubin  Colorimetric (DCA) 
α-Tochopherol HPLC 
β- Carotene HPLC 
Lycopene HPLC 
Retinol HPLC 
 
Hemoglobin: 
Hemoglobin determinations were performed by the Orphee MYTHEC 18 clinical 
analyzer from a tube of well-mixed EDTA-anticoagulated blood filled to a 
predetermined level. In this assay, all forms of hemoglobins are converted to 
the colored protein cyanomethemoglobin and measured by a colorimeter. The 
coefficient of variation of this method was 3%.  
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Ferritin: 
The method for the measurement of ferritin was immuno-turbidimetry using 
Parsazmun's kits (Parsazmun Co. INC) on the Hitachi 912 clinical analyzer. 
Latex-bound Ferritin antibodies react with the antigen in the sample to form an 
antigen/antibody complex. Following agglutination, this is measured 
turbidimetrically. Turbidity is proportional to the ferritin concentration, and is 
measured at 700 nm (primary wavelength).The intra-assay coefficient of 
variation for this method using this kit was 3.8% and the inter-assay coefficient 
of variation was 4.7%. 
 
Serum iron: 
Serum iron was measured using Ferene method (Burtis and Ashwood, 1994). 
Parsazmun's iron assay kit (Parsazmun Co. INC) provides a simple convenient 
means of measuring Ferrous and/or Ferric ion in samples. In the assay, ferric 
carrier protein dissociates ferric into solution in the presence of an acid buffer. 
After reduction to the ferrous form (Fe2+), iron reacts with Ferene S to produce 
a stable colored complex and give absorbance at 593 nm. A specific chelate 
chemical is included in the buffer to block copper ion (Cu2+) interference. The 
coefficient of variation of this method was 2.93%.  
 
Transferrin (and TIBC): 
In order to measure transferring saturation (TS), transferrin was measured 
using Parsazmun's kits (Parsazmun Co. INC) (immunoturibidimetric method) 
(Cook et al, 1974). In this method, a reaction occurs between transferrin and 
polyclonal antibodies that yields a turbid solution. The turbidity of the solution is 
proportional to the concentration of transferrin in the sample. In order to 
measure TIBC (µg/dl), this concentration [transferrin (mg/gl)] multiplied by 1.25. 
The coefficient of variation of this method was 3%.  
 
Serum transferrin receptor:  
Serum transferrin receptor was measured using DRG's kit (DRG diagnostic, 
Germany). This assay is based on the microplate sandwich enzyme 
immunoassay technique using two different monoclonal antibodies specific for 
sTfR. Samples or standards are pipetted into wells of a microplate pre-coated 
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with a monoclonal antibody that can capture sTfR, thereby immobilizing sTfR to 
the well. After washing away any unbound protein, a second anti-sTfR 
monoclonal antibody conjugated to horseradish peroxidase is added. The 
conjugated antibody completes the sandwich. After washing away unbound 
conjugated antibody, the amount of conjugate remaining in the well is 
proportional to the amount of sTfR initially captured. The amount of conjugated 
enzyme in the well is measured by incubation with a chromogenic substrate. 
The intra-assay coefficient of variation for this method was 7.1% and the inter-
assay coefficient of variation was 6.4%. 
 
Malondialdehyde (MDA):  
Serum MDA levels were measured as an index of lipid peroxidation according 
to the Thiobarbituric acid (TBA) spectrophotometric method that was introduced 
by Satoh   (Satoh, 1978) with minor modifications. The coefficient of variation of 
this method was 5%.  
 
Total Antioxidant Capacity (TAC):  
2, 2’-azinobis (3-ethylbenzothiazolin 6-sulfate) or ABTS produces ABTA cation 
radical (ABTS°+) under the influence of potassium persulfate. The original ABTS 
solution is colorless turning to green-blue after adding potassium persulfate and 
forming cation radical. This solution becomes stable after 24hrs and keeps its 
stability for another 48 hours. Maximum absorption occurs at 415 nm, 645nm, 
734nm, and 815nm. Adding antioxidant solution to this in a given time, color 
intensity decrease depending on antioxidant activity and concentration. 
Therefore, decolorization is expressed as a percent of ABTS°+ inhibition based 
on the difference of the primary and secondary absorbance divided by primary 
absorbance multiplied by 100. Standard curve of bovine serum albumin (BSA) 
is used to convert inhibition percentage to g/dl. The intra-assay coefficient of 
variation for this method was 1.6% and the inter-assay was 4%. 
 
Superoxide dismutase (SOD):  
The SOD activity of serum was measured with Cayman's Superoxide 
Dismutase assay kit (Cayman chemical company, USA). This method utilizes a 
tetrazolium salt for detecting superoxide radicals generated by xanthine oxidase 
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and hypoxanthine. One unit of SOD is defined as the amount of enzyme 
needed to exhibit 50% dismutation of the superoxide radical. Scheme of the 
super oxide dismutase assay is shown in figure 6.  
 
 
Figure 6. Scheme of the superoxide dismutase assay 
The intra-assay coefficient of variation for this method was 3.2% and the inter-
assay coefficient of variation was 3.7%. 
 
Glutathione peroxidase (GPx):  
Glutathione peroxidase (GPx) catalyzes the reduction of hydroperoxides, 
including hydrogen peroxide, by reduced glutathione and functions to protect 
cells from oxidative damage.  
Serum GPx activity was evaluated with Cayman GPx assay kit (Cayman 
chemical company, USA). Cayman's GPx assay measures GPx activity 
indirectly by a coupled reaction with glutathione reductase (GR) (Pagila and 
Valentine, 1967). Oxidized glutathione (GSSG), produced upon the reduction of 
hydroperoxide by GPx, is recycled to its reduced state by GR and NADPH. This 
reaction is presented in figure 7. 
 
Figure 7. Scheme of glutathione peroxidase assay 
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The intra-assay coefficient of variation by using this method is 5.7% and the 
inter-assay coefficient of variation was 7.2%. 
 
Oxidized LDL:  
The Mercodia Oxidized LDL ELISA kit (Sweden) was used for quantitative 
measurement of oxidized low density lipoprotein. Mercodia Oxidized LDL ELISA 
is a solid phase two-site enzyme immunoassay. It is based on the direct 
sandwich technique in which two monoclonal antibodies are directed against 
separate antigenic determinants on the oxidized apolipoprotein B molecule. 
During incubation, oxidized LDL in the sample reacts with anti-oxidized LDL 
antibodies bound to microtitration well. After washing, which removes non-
reactive plasma components, a peroxidase conjugated anti-human 
apolipoprotein B antibody recognizes the oxidized LDL bound to the solid 
phase. After a second incubation and a simple washing step that removes 
unbound enzyme labeled antibody, the bound conjugate is detected by reaction 
with 3, 3', 5, 5'-tetramethylbenzidine (TMB). The reaction is stopped by adding 
acid to give a colorimetric endpoint, and is then read spectrophotometrically. 
Serum oxidized LDL levels were measured by a competitive ELISA utilizing a 
specific murine monoclonal antibody mAb-4E6 (Holveot et al, 2001). 
The coefficient of variation of this method using this kit was 8.3%. 
 
Protein Carbonyl (PC):  
Protein carbonyls were measured by using OxiSelect Protein Carbonyl ELISA 
kit (Cell Biolabs, USA) following the protocol provided by the manufacturer. Cell 
Biolabs’ Protein Carbonyl ELISA Kit is an enzyme immunoassay developed for 
rapid detection and quantitation of protein carbonyls. The quantity of protein 
carbonyls in protein samples is determined by comparing its absorbance with 
that of a known reduced/oxidized BSA standard curve. BSA standards or 
protein samples (10µg/ml) are adsorbed onto a 96-well plate for 2 hrs at 37ºC. 
The protein carbonyls present in the sample or standard are derivatized to DNP 
hydrazone and probed with an anti-DNP antibody, followed by an HRP 
conjugated secondary antibody. The protein carbonyl content in the unknown 
sample is determined by comparing with a standard curve that is prepared from 
predetermined reduced and oxidized BSA standards (Buss et al, 1985). In terms 
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of assay variation, based on this test, the intra-assay coefficient of variation was 
6% and the inter-assay coefficient of variation was 8%.  
 
Serum Albumin: 
Serum albumin levels were measured using Bromocresol green method 
(Parsazmun Co. INC). In this method, Albumin in the sample reacts with 
bromocresol green in an acid medium forming a coloured complex that can be 
measured by spectrophotometry (Doumas et al, 1971). The coefficient of 
variation for this method was 1.79%. 
 
Uric Acid:  
Uric acid is a metabolic product of exogenous or endogenous purine bases. 
Since uric acid is found in human serum in relatively low concentrations, it is 
necessary to use specific and sensitive methods for its determination. In this 
study, uric acid levels were measured using colorimetric (TOOS) method 
(Jelikic-Stankov et al, 2003). This is a specific enzymatic method. It involves the 
catalytic oxidation of uric acid with the enzyme uricase to allantoin with the 
formation of hydrogen peroxide. The peroxide, the concentration of which is 
directly proportional to the concentration of uric acid, can be determined by 
colorimetric methods using N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline 
(TOOS). Intra-assay coefficient of variation for this method was 2.2% and inter-
assay coefficient of variation was 2.7%. 
 
Total Protein:  
The serum total protein, as its name implies, represents the sum total of 
numerous different proteins, many of which vary independently of each other. 
Total protein was measured using Biuret method Parsazmun kit (Reinhold, 
1953). Proteins form a purple colored complex with cupric ions in an alkaline 
solution. The reaction takes its name from the simple compound Biuret which 
reacts in the same way. The intensity of the purple color is measured at 540 nm 
/ yellow green filter and compared with a standard serum of known protein 
concentration. The coefficient of variation for this method was 1%. 
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Total Bilirubin:  
Total bilirubin was measured using the colorimetric (DCA) method (Rand and 
Dipasqua, 1962). At least four distinct bilirubin species exist in the serum: 
Direct-reacting bilirubin (DB) consisting of mono and diconjugated bilirubin (β 
and γ-Bilirubin), δ-fraction which is bilirubin tightly bound to albumin, and 
unconjugated α-bilirubin which is water soluble and bound to albumin. The 
reaction between DB and diazotised dichloroaniline leads to a compound, 
azubilirubin, whose absorbance is directly proportional to the concentration of 
DB in the specimen and is measured at 550 nm. The coefficient of variation for 
this method was 2%.   
  
Serum α–Tocopherol, β-Carotene, Lycopene, and Retinol: 
Serum levels of beta-carotene, lycopene, α-tocopherol, and retinol were 
determined using the HPLC method as described by Neyestani et al (Neyestani 
et al, 2007) but with some minor modifications. Serum samples obtained from 
patients were immediately frozen and stored at -80° C until they were used for 
HPLC analysis. After examining various chromatographic conditions, the 
following method was found to be the most reliable. After protein precipitation 
with ethanol, carotenoids, α-tocopherol, and retinol were extracted using n-
hexane, which was then evaporated under nitrogen flow at 40°C. The sediment 
was reconstituted with a mixture of mobile phase (methanol: acetonitrile: 
tetrahydrofurane, 50:45:5, v/v/v) and diethyl ether (2:1, v/v), 20µL of which was 
injected to the column Novopack C18. 
 
Instrument specification for HPLC: 
Column                    C18 Novapak 3.9 ×150 
Flow rate                 1.5 ml/min 
Temperature           ambient room 
Pressure                 1100 PSA 
Wavelent                 retinol: 325, α-tocopherol: 292nm,  
                                 lycopene: 472nm, β-carotene: 450nm 
Retention time         retinol: 1.5 min, retinol acetate: 1.9 min,  
                                 α-tocopherol: 5.6, lycopene: 12.5, beta carotene: 12.9 
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Run time                   20 min 
Loop volume            20µl    
 
The intra-assay coefficient of variation for this method was 6.5% and the inter-
assay coefficient of variation was 4.8%. 
 
4-8 Quality Control & Quality Assurance 
Once flour fortification starts, the flour industry must have in place a strong 
quality assurance/quality control (QA/QC) system, and appropriate food control 
and regulatory monitoring procedures must be followed to ensure that safe and 
adequately fortified flour (according to national standards) is continuously 
produced to meet the dietary and nutritional needs of the population (Pena-
Rosas et al, 2008). In our study, we organized a workshop to train laboratory 
managers of the flour factories. They were trained to take at least 2-3 fortified 
flour samples every day. Using the spot test (Nalubola and Nestel, 2000), they 
were asked to check the fortification process in the factory (as QC) .Central 
Food and Nutrition lab (CFNL) in the province also had regular visits from flour 
factories and took some samples of fortified flour for quantitative test to detect 
the exact amount of iron in the fortified flour (As QA). In CFNL, the iron content 
was assayed using a spectrophotometric method (AACC 40-41B). This method 
determines iron content by reaction with orthophenanthroline and 
spectrophotometric measurement (Nalubola and Nestel, 2000). In terms of the 
iron level in bread (or flour), we expected to have four levels of fortification: low 
was defined as 25–39.9 mg/kg, good as 40–65.9 mg/kg, acceptable as 66–79.9 
mg/kg and high as ≥80 mg/kg. These ranges were taken from the guidelines of 
the iron assay method (Allen et al, 2006). To ensure that the observations were 
true and due to flour fortification, we also took some regular fortified flour 
samples from bakeries and sent them to a different laboratory to check the 
exact amount of iron and compared these results with the results of CFNL as 
double check. 
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4-9 Statistical analysis 
Data was expressed as means and standard deviations.When the distribution of 
variables was not normal, the data were expressed in median and inter-quartile 
range (IQR). The normality of the distribution of variables was tested using the 
kolmogorov smirnov test. The Naperian logarithm transformation of values was 
performed to make data fit to the normal distribution when the distribution was 
not normal. The analysis of variance (ANOVA) was used to identify any 
difference among groups in the three phases. Multiple comparisons among 
phases were done using the Bonferroni and Dunnett post-hoc tests. 
Nonparametric test of Kruskal-Wallis was used for those distributions which 
were not normal. Linear relationships between serum values were examined 
using Pearson’s correlation coefficient.  
 Analysis of the data was done by SPSS software version 14 using the 
dependent test in each group and the independent test between groups 
regarding the type and the distribution of variables. Analysis of consumed foods 
was done by Food Processor II software. For all hypotheses, a significance 
level of P<0.05 was considered statistically significant. 
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4-10 Research variables:  
Variables 
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Quantitative Qualitative 
Measurement 
tools Unit 
Co
n
tin
u
es
 
D
is
cr
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e 
N
o
m
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O
rd
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al
 
Survey group 
*    *  _ 
Control and 
intervention 
group 
Time of intervention 
*  *    
weeks after 
fortification 
0, 32, and 64 
weeks  
Age 
*   *   
Identification 
Card 
year 
Sex *    *  See person Men-women 
Weight 
*  *    
Using Seca 
scale 
kg 
Height 
*  *    
Using Seca 
height 
measurements 
cm 
BMI *  *    Calculator Kg/m
2 
BMI 
*     * - 
25>        =  0 
25-29.9 =  1 
>30        =  2 
Literacy level 
*     * Question 
1-No literacy 
2- Primary 
school 
3-Junior and 
high school 
4-Diploma/ 
university 
 
 
Iron supplements 
Intake *    *  Question 
Yes- no 
Surgery history *    *  Question Yes-no 
Blood donation 
history *    *  
Question 
 
Yes-no 
Inflammation history 
in two weeks before *    *  Question Yes-no 
Alcohol intake *    *  Question Yes-no 
Hemoglobin 
 * *    CBC gr/dl 
Hematocrit 
 * *    CBC % 
Serum iron 
 * *    Lab test µgr/dl 
Total Iron Binding 
Capacity (TIBC)  * *    Lab test 
% 
Transferrin 
saturation(TS)  * *    Lab test % 
Serum ferritin(Sf) 
 * *    Lab test ng/ml 
Serum Transferrin 
Receptor(STfR)  * *    Lab test nmol/l 
Total Protein 
 * *    Lab test gr/dl 
Albumin 
 * *    Lab test gr/dl 
Uric acid 
 * *    Lab test mg/dl 
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Research variables Continue…. 
Variables 
In
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Quantitative Qualitative 
Measurement 
tools Unit 
Co
n
tin
u
es
 
D
is
cr
et
e 
N
o
m
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al
 
O
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al
 
Bilirubin 
 * *    
Lab test mg/dl 
Blood pressure 
 * *    
Lab test mmHg 
Malondialdehyde 
(MDA)  * *    
Lab test µmol/l 
Total Antioxidant 
Capacity(TAC)  * *    
Lab test µmol/l 
Super Oxide 
Dismutase(SOD)  * *    
Lab test U/ml 
Glutathione 
Reductase(GPx)  * *    
Lab test U/ml 
Protein 
Carbonyl(PC)  * *    
Lab test nmol/mg 
Oxidized 
LDL(OxLDL)  * *    
Lab test µmol/l 
α -Tocopherol 
 * *    Lab test mgr/dl 
β-Carotene 
 * *    Lab test µgr/dl 
Lycopene 
 * *    Lab test µgr/dl 
Retinol 
 * *    Lab test µgr/dl 
Iron intake  * 
 
*    Quantitative 
FFQ 
mg/day 
Copper Intake * 
 
*    Quantitative 
FFQ 
mg/day 
Zinc Intake *  *    Quantitative 
FFQ 
mg/day 
Vitamin C, Intake *  *    Quantitative 
FFQ 
mg/day 
Vitamin A, Intake *  *    Quantitative 
FFQ 
IU/day 
Vitamin E, Intake *  *    Quantitative 
FFQ 
mg/dl 
Multivitamin 
Supplement  intake 
*  *    Question Yes-no 
Physical activity 
Level 
*     * Questionnaire -Under 
active 
-Moderate 
-Active 
Cigarette smoking *   *   Questionnaire Number/d
ay 
Energy intake *  *    24 hour recall Kcal 
Protein intake *  *    24 hour recall gr/day 
Fat intake *  *    24 hour recall gr/day 
PUFA intake *  *    24 hour recall mg/day 
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5   RESULTS 
Based on our study design, data was presented in three sections: 
5-1 Baseline characteristics before intervention  
5-2 Field trial after 32 weeks 
5-3 Effects of iron fortified flour consumption after 64 weeks (before and 
after study) 
 
 
5-1 Baseline Characteristics before Intervention  
To investigate any difference among the study groups in the two cities at the 
beginning of the study, the main study variables were compared in this part.  
Of the 396 volunteers who entered the study at baseline data collection, full 
data was obtained from 330 volunteers due to inclusion and exclusion criteria 
(Table 5-1-1).  
 
Table 5-1-1. The number of males and females at the time of baseline data collection in the two 
cities 
 
Gender 
City  
Total Damgan Semnan 
Male 87 78 165 
Female 82 83 165 
Total 169 161 330 
 
The inverse relationship between oxidative stress and education is to be 
expected because educated persons are less likely to be obese (Winkleby et al, 
1998) and are more likely to adopt dietary and other lifestyle practices 
consistent with higher antioxidant status.  
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As Table 5-1-2 and 5-1-3 show, there was no significant difference in the level 
of literacy among study groups in two cities at the time of baseline data 
collection. 
 
Table 5-1-2. Level of literacy among males at the time of baseline date collection in the two 
cities 
city 
 
Illiterate Primary school Junior and 
High school 
Diploma and 
university 
P value 
Damgan (n=87)  1% 25% 24% 50% 0.59 
Semnan (n=78) 4% 21% 20% 55% 
The Fisher’s exact test showed no significant difference in the two groups 
 
Table 5-1-3. Level of literacy among females at the time of baseline date collection in two cities 
city 
 
Illiterate Primary school Junior and 
High school 
Diploma and 
university 
P value 
Damgan (n= 82) 9% 42% 14% 35% 0.68 
Semnan (n= 83) 13% 33% 18% 36% 
The Chi-square test showed no significant difference in the two groups 
 
As mentioned earlier in statistical analysis, the normality of the distribution of 
variables was tested using the Kolmogorov-Smirnov test. To compare the mean 
of the variables among study groups between two cities at baseline, 
independent t-test was used. 
The means and standard deviations (SD) of age, BMI, systolic and diastolic 
blood pressure are presented in table 5-1-4.  
Aging is a process of deleterious and progressive changes in multiple organ 
systems. With aging, oxidant production in skeletal muscle may exceed the 
antioxidant capacity to buffer oxidants, resulting in oxidative damage. The mean 
age of males and females, as shown in table 5-1-4, was not significant at 
baseline in the two cities.  
Body mass index was measured by dividing weight in kilograms by height in 
meters squared. The normal range for BMI in this study was between 20 and 
25. A BMI more than 25 and less than 30 was considered overweight, and a 
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BMI more than 30 was considered obese. Means and SDs of BMI of the 
subjects did not show any significant difference among males and females in 
two cities at the baseline of the study (table 5-1-4). 
Hypertension is associated with increased vascular oxidative stress; however, 
there is still debate whether oxidative stress is a cause or a result of 
hypertension. Based on the data presented in table 5-1-4, there was no 
significant difference in systolic and diastolic blood pressure among study 
groups at the baseline of the study. 
 
Table 5-1-4. Baseline characteristics of males and females in intervention group (Semnan) 
and control group   (Damgan)  
City 
Sex Variables 
P value 
Semnan  
Mean(± SD) 
Damgan  
Mean(± SD) 
0.87 50.4 ± 6.4 50.9 ± 6.9 Male* 
Age (year) 
0.68 50.0 ± 6.0 49.4 ± 6.5 Female**  
0.97 26.8 ± 3.6 26.9 ± 5.2 Male 
BMI (kg/m2) 
0.20 31.3 ± 5.7 30.2 ± 4.2 Female 
0.73 120.7 ± 12.1 119.9 ± 13.2 Male 
Systolic blood 
pressure (mmHg) 0.17 121.7 ± 16.3 117.9 ± 15.8 Female 
0.21 78.3 ± 11.1 75.3 ± 8.4 Male 
Diastolic blood 
pressure (mmHg) 0.15 82.1 ± 12.0 78.5 ± 10.6 Female 
   Independent t-test showed no significant difference between the two groups in the two cities 
*n= 78 in Semnan, n=87 in Damgan    
**n=83 in Semnan, n= 82 in Damgan  
 
 
The means and SDs of iron status and some endogenous antioxidant 
parameters in males and females at the baseline of the study are presented in 
table 5-1-5. 
To determine the iron status in the body, hemoglobin, ferritin, serum iron, total 
iron binding capacity, transferrin saturation, and serum transferrin receptors 
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were measured in our study. Measuring the level of serum iron is one of the 
most frequently performed diagnostic tests for trace elements. Evaluation of iron 
(IRN), total iron binding capacity (TIBC), and the calculated ratio of iron 
concentration and total iron binding capacity [(IRN/TIBC) * 100 =% TS] are 
useful for the differential diagnosis of anemia and iron overload and monitoring 
the treatment of certain disease conditions. Serum ferritin is believed to be the 
best determinant for evaluating body iron stores as 1ng of serum ferritin 
corresponds to 8 mg of stored iron in the absence of inflammation, MI, or other 
critical events. The soluble fraction of transferrin receptor can be also measured 
which is considered to be the best parameter describing iron stores even in the 
presence of inflammation.  
Mean values of the hemoglobin and ferritin showed no significant difference in 
males and females at baseline in the two cities (table 5-1-5). 
Independent t-test did not show significant changes in serum transferrin 
receptor, serum iron, TIBC, and transferrin saturation (TS) among males and 
females in the two cities at the baseline of the study (table 5-1-5).  
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Table 5-1-5. Mean and standard deviation of iron status and some endogenous antioxidant 
parameters of males and females at baseline in Semnan and Damgan 
City 
Sex Variables 
P value 
Semnan  
Mean(± SD) 
Damgan  
Mean(± SD) 
0.98 14.3 ± 0.8 14.3 ± 0.8 Male* 
Hemoglobin (gr/dl) 
0.56 13.0 ± 0.6 12.8 ± 0.7 Female** 
0.09 157.5  ± 57.9 143.5  ± 47.1 Male 
Ferritin (ngr/ml) 
0.65 98.4 ± 40.2 98.9 ± 39.7 Female 
0.13 1.3 ± 0.3 1.2 ± 0.2 Male 
Serum transferrin 
receptor (µgr/ml) 0.13 1.4 ± 0.6 1.3 ± 0.4 Female 
0.97 100.1 ± 29.7 101.2 ± 29.6 Male 
Serum iron (µgr/dl) 
0.50 94.0 ± 31.4 90.2 ± 31.1 Female 
0.15 299.3 ± 72.6 321.2 ± 75.9 Male 
Total iron binding 
capacity (TIBC)(µgr/dl) 0.70 289.9 ± 76.1 295.2 ± 72.9 Female 
0.24 31.7 ± 11.5 33.9 ± 11.9 Male 
Transferrin saturation 
(TS) (%) 0.33 28.5 ± 11.9 30.6 ± 12.6 Female 
0.13 4.0 ± 0.3 3.9 ± 0.2 Male 
Albumin (gr/dl) 
0.08 4.0 ± 0.3 3.9 ± 0.3 Female 
0.60 1.03 ± 0.42 1.11 ± 0.55 Male 
Total Bilirubin (µgr/d) 
0.26 0.82 ± 0.28 0.89 ± 0.35 Female 
0.16 7.1 ± 0.4 7.0 ± 0.5 Male 
Total protein (gr/dl) 
0.11 7.2 ± 0.6 7.0 ± 0.4 Female 
0.13 5.3 ± 1.0 4.9 ± 1.2 Male 
Uric acid (mg/dl) 
0.80 4.6 ± 1.1 4.6 ± 1.1 Female 
Independent t-test did not show any significant differences between two groups in two cities 
*n= 78 in Semnan, n=87 in Damgan   
 **n=83 in Semnan, n= 82 in Damgan  
 
Serum levels of albumin, total bilirubin, total protein, and uric acid are shown in 
the table 5-1-5 as well.   
Uric acid is the final product of purine metabolism in humans. The final two 
reactions of its production catalyzing the conversion of hypoxanthine to xanthine 
and the latter to uric acid are catalyzed by the enzyme xanthine oxidoreductase, 
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which may attain two inter-convertible forms, namely xanthine dehydrogenize or 
xanthine oxidase. The latter uses molecular oxygen as electron acceptor and 
generates superoxide anion and other reactive oxygen products. The role of 
uric acid in conditions associated with oxidative stress is not entirely clear. 
Evidence mainly based on epidemiological studies suggests that increased 
serum levels of uric acid are a risk factor for cardiovascular diseases where 
oxidative stress plays an important pathophysiological role. 
As early as 1959, it was suggested that bilirubin might be an antioxidant. 
Bilirubin can act as an important cytoprotector of tissues that are poorly 
equipped with antioxidant defense systems including myocardium and nervous 
tissue. Bilirubin, when bound to human albumin and at concentrations present 
in normal human plasma, protects albumin-bound linoleic acid from peroxyl 
radical-induced oxidation in vitro (Baranano et al, 2002). 
Albumin, the major serum protein, has a cystein residue in position 34 which is 
not involved in a disulfide bond and may exist in different oxidation states: as a 
fully reduced sulfhydryl group, as a mixed disulfide with cystein, glutathione or 
homocystein, or in higher oxidation states such as sulfenic, sulfinic or sulfonic 
acid. Serum albumin is known to act as an antioxidant. The oxidation state of 
human serum albumin is discussed as a marker for systemic oxidative stress 
and it has been shown that disulfide content of serum albumin is increased by 
strenuous exercise in older people and in the course of different diseases. 
Comparing mean values for albumin, total bilirubin, total protein, and uric acid, 
as shown in table 5-1-5, showed no significant difference between males and 
females in two cities at the baseline of the study.  
Mean values of some oxidative stress biomarkers and dietary antioxidants are 
presented in table 5-1-6. 
Malondialdehyde (MDA) is one of the most frequently used indicators of lipid 
peroxidation. Lipid peroxides are formed as a consequence of free radical 
attack on polyunsaturated fatty acids. The polyunsaturated fatty acids break 
down in the presence of iron or other metals forming aldehydes e.g. 
51 
 
malondialdehyde (MDA) via the formation of cyclic peroxides and 
endoperoxides (precursors of prostaglandin).  
To determine the antioxidant capacity of the serum, we used total antioxidant 
capacity (TAC). Antioxidants play an important role in preventing the formation 
of and scavenging free radicals and other potentially toxic oxidizing species.  
Oxidized LDL is a form of low-density lipoprotein (LDL), or "bad" cholesterol that 
has been bombarded with oxygen to yield free radicals when it enters into the 
wall of an artery. 
Superoxide dismutases (SOD) are a class of enzymes that catalyse the 
dismutation of superoxide into oxygen and hydrogen peroxide. They are an 
important antioxidant defense in nearly all cells exposed to oxygen. 
Glutathione peroxidase (GPx) is the general name of an enzyme family with 
peroxidase activity whose main biological role is to protect the organism from 
oxidative damage. One of the biochemical functions of glutathione peroxidase is 
to reduce free hydrogen peroxide to water. 
Protein carbonyl (PC) is the most general indicator and by far the most 
commonly used marker of protein oxidation. Redox cycling cations such as Fe2+ 
or Cu2+ can bind to the cation binding locations on proteins and with the aid of 
further attack by H2O2 or O2 can transform side-chain amine groups on several 
amino acids (such as Lysine, Argenine, Proline) into carbonyls. 
The independent t-test did not show significant changes in MDA, TAC, SOD, 
GPx, PC, and oxidized LDL of males and females in the two cities at the 
baseline of the study. 
Lycopene and β-carotene are two strong antioxidant carotenoids. Carotenoids 
contribute to antioxidant activity in cellular lipids, support normal cellular growth 
and renewal, and assist healthy levels of immune cell activity. Carotenoids 
promote cardiovascular health including support for a healthy antioxidant 
response to LDL cholesterol. Beta carotene is one of the most important natural 
antioxidants. There is no RDA for beta carotene. 
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Alpha tocopherol is the main form of vitamin E and is most commonly studied 
dietary antioxidant supplement in clinical trials. 
Retinol, the main circulating form of vitamin A, has a free radical scavenging 
potential. 
The mean values of dietary antioxidants such as serum retinol (vitamin A), 
alpha tocopherol (Vitamin E), beta carotene, and lycopene, as presented in 
table 5-1-6, showed no significant difference between males and females in two 
cities at the baseline of the study.  
 
 Table 5-1-6. Mean and standard deviation of oxidative stress and dietary antioxidants of female 
and male participants at the baseline and after 32 weeks in Semnan and Damgan 
City 
Sex Variables 
P value 
Semnan  
Mean(± SD) 
Damgan  
Mean(± SD)  
0.92 2.9 ± 1.1 3.0 ± 0.9 Male* Malondialdehyde,   
MDA (µmol/L) 0.52 2.8 ± 1.0 2.9 ± 1.1 Female** 
0.87 1.87 ± 0.24 1.82 ± 0.21 Male Total antioxidant capacity, 
TAC ((µmol/L) 0.48 1.83 ± 0.25 1.86 ± 0.18 Female 
0.30 0.58 ± 0.20 0.59 ± 0.20 Male Superoxide dismutase, 
SOD (U/ml) 0.38 0.58 ± 0.23 0.55 ± 0.25 Female 
0.39 174.6 ± 35.3 178.2 ± 39.2 Male Glutathione peroxidase, 
GPx (U/ml/min) 0.95 183.5 ± 35.5 181.4 ± 31.8 Female 
0.20 2.29 ± 0.27 2.22 ± 0.26 Male Protein carbonyl,  
 PC (nmol/mg) 0.69 2.26 ± 0.59 2.25 ± 0.54 Female 
0.75 181.8 ± 61.6 185.1 ± 64.2 Male Oxidized LDL (µmol/L) 
0.68 188.9 ± 81.0 198.4 ± 61.5 Female 
0.23 73.3 ± 26.1 78.6 ± 22.6 Male Vitamin A (µgr/dl) 
0.92 73.2 ± 24.4 73.1 ± 24.0 Female 
0.34 1.33 ± 0.50 1.39 ± 0.40 Male Vitamin E (mg/dl) 
0.68 1.49 ± 0.52 1.52 ± 0.56 Female 
0.06 50.0 ± 21.0 57.5 ± 21.8 Male Lycopene (µgr/dl) 
0.13 53.1 ± 19.5 64.3 ± 26.4 Female 
0.44 25.0 ± 12.1 27.9 ± 14.1 Male 
β-carotene (µgr/dl) 
0.26 26.8 ± 13.3
 
26.5 ± 12.7 Female 
Independent T-test showed no significant difference between the two groups in the two cities 
*n= 78 in Semnan, n=87 in Damgan   
 **n=83 in Semnan, n= 82 in Damgan  
 
In order to find differences in subjects' dietary intakes among study groups at 
the baseline of the study, data obtained from three-day 24-hour recall for intake 
of total energy, total protein, total fat, and polyunsaturated fatty acids (PUFA) 
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and food frequency questionnaire (quantitative) for vitamin C, vitamin A, vitamin 
E, iron, zinc, and copper were studied. 
Comparing means and standard deviations of energy, macronutrients, iron, 
zinc, copper, and antioxidant vitamins intake as presented in table 5-1-7 did not 
show any significant differences between males and females in two cities at the 
baseline of the study. 
The World Health Organization and many national health agencies have 
independently conducted studies and even though they differ slightly, all have 
concluded that our daily protein requirement should be between 10 to 15 
percent of our daily caloric intake. In the present study, the mean value of the 
percent of protein from energy was about 12.5 percent for both males and 
females and there was no significant difference at the baseline of the study in 
each gender in two cities.   
USDA Dietary Guidelines of 2005 recommends that total fat intake should count 
between 20 to 35 percent of energy for adults. No more than 10 percent of 
energy should be from saturated fats (there is no dietary guideline for Iranian 
population at the moment). In our study, the means of energy intake are 
presented in table 5-1-7. The mean percentage of energy produced from fat in 
males and females was between 25 to 26 percent and about 29 percent at the 
baseline, respectively. There were no statistically significant differences within 
males and females in fat intake at the baseline of the study (table 5-1-7).   
The National Heart, Lung, and Blood Institute recommends that up to 10% of 
total daily energy should be from PUFA. Double bonds in PUFA can lead to 
formation of free-radicals and reactions with oxygen to form unstable lipid 
peroxide compounds containing the same unstable oxygen bond found in 
hydrogen peroxide. Although polyunsaturated fatty acids may have a protective 
effect against atherosclerosis, moderation in consumption is recommended. In 
our study, the mean value of the percent of PUFA from energy in males and 
females was between 8.3 and 8.9 percent and between 10.3 and 10.7 percent 
at baseline, respectively. Females' PUFA intake was a little bit more than what 
is recommended (10%) but there was no significant difference between females 
in the two cities (table 5-1-7). 
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Vitamin C is the major water-soluble antioxidant and its reducing power is used 
in radical and nonradical redox reactions. It is considered to be the most 
important antioxidant in extra cellular fluids and has many cellular activities of 
an antioxidant nature as well. It was shown that ascorbic acid was far more 
effective in inhibiting lipid peroxidation initiated by a peroxyl radical initiator than 
other plasma components, such as protein thiols, urate, bilirubin, and α-
tocopherol. The recommended amount by RDA for non-smoker adult males and 
females is 90 and 75 mg, respectively. In this study, the mean value of vitamin 
C intake for males was about 90 mg but females had a higher vitamin C intake 
than RDA recommendation (93.3 mg in Semnan and 89.5 mg in Damgan). 
Although the mean value of vitamin C in females was more than RDA (75 mg), 
there was no significant difference in the two cities at the baseline of the study 
(table 5-1-7). 
Vitamin A participates in several primordial functions in human systems playing 
a role in visual acuity, cellular proliferation and differentiation. It also shows 
antioxidant properties and immunological activities. The recommended amount 
by RDA for Vitamin A is 900 mg / day RAE. As table 5-1-7 shows, the mean 
value of vitamin A intake for males and females in the two cities was less than 
RDA, but there was no statistically significant difference in males and females in 
two cities at the baseline of the study. 
Vitamin E is a fat-soluble vitamin which has antioxidant properties. Natural 
vitamin E exists in eight chemical forms (alpha-, beta-, gamma-, and delta-
tocopherol and alpha-, beta-, gamma-, and delta-tocotrienol) that have varying 
levels of biological activity. Alpha- (or α-) tocopherol is the only form that is 
recognized to meet human requirements. Recommended dietary allowance for 
vitamin E (α-tocopherol) for adult males and females is 15 mg. In the present 
study, the mean values of vitamin E intake for males and females in Semnan 
and Damgan were 9.3, 9.1, 9.2 and 8.7 mg, respectively. There were no 
statistically significant differences in vitamin E intake in males and females at 
the baseline of the study (table 5-1-7).   
Iron, the most prevalent metal in the body, reacts with hydrogen peroxide and 
catalyzes the generation of highly reactive hydroxyl radicals, thereby increasing 
oxidative stress, which in turn increases free iron concentrations by the Fenton 
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and Haber–Weiss reaction. Excessive iron intake from either foods or dietary 
supplements can be a source of ROS, although results from epidemiologic 
studies are inconsistent. The oxidative stress produced by dietary intake of iron 
might be modified by endogenous oxidant and antioxidant capabilities that may 
act in concert to provide a coordinated network of protection against ROS 
accumulation and oxidative damage. The current iron RDA for postmenopausal 
women (ages 50+) and all men is 8 mg per day. The RDA for premenopausal 
women (ages 19 to 50) is 18 mg per day. 
The difference in mean intake of iron, as shown in table 5-1-7, was not 
significant in males and females in Semnan and Damgan at the baseline of the 
study. 
The relevance of zinc for proper functioning of the entire immune system is 
already well documented. It is quite clear that antioxidants and micronutrients in 
the diet, such as zinc, influence the development and function of immune cells, 
the activity of stress-related proteins and antioxidant enzymes and help to 
maintain genomic integrity and stability. Recommended dietary allowance for 
zinc for adult males and females is 11 and 8 mg, respectively. In the present 
study, the mean values of zinc intake in Semnan and Damgan males and 
females were 7.75, 8.34, 6.85 and 7.26 mg, respectively. There was no 
statistically significant difference between males and females in zinc intake at 
the baseline of the study (table 5-1-7). 
Copper (Cu), a redox active metal, is an essential nutrient for all species studied 
to date. It is an integral part of many important enzymes involved in a number of 
vital biological processes. Although normally bound to proteins, Cu may be 
released and become free to catalyze the formation of highly reactive hydroxyl 
radicals. Data obtained from in vitro and cell culture studies are largely 
supportive of Cu's capacity to initiate oxidative damage and interfere with 
important cellular events. Vitamin E is generally protective against Cu-induced 
oxidative damage. Interestingly, a deficiency in dietary Cu also increases 
cellular susceptibility to oxidative damage. Recommended dietary intake of 
copper (Cu) for adults is 900 µgr/day. In the present study, the mean values of 
copper intake for males and females in Semnan and Damgan were 1.89, 2.02, 
1.67 and 1.81 mg, respectively. There were no statistically significant 
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differences in copper intake in males and females at the baseline of the study 
(table 5-1-7).  
Table 5-1-7 Energy, macronutrients, iron, zinc, copper, and antioxidant vitamins intake of males 
and females at baseline in the intervention group (Semnan) and the control group (Damgan) 
City 
Sex Variables 
P value 
Semnan  
Mean(± SD) 
Damgan  
Mean(± SD) 
0.68 2218.9 ± 646.0 2174.8 ± 501.5 Man* Energy (kcal) 
0.08 1687.2 ± 471.6 1569.7 ± 501.2 Women** 
0.53 68.8 ± 22.1 66.3 ± 17.5 Male Protein (gr) 
0.17 53.2 ± 17.1 48.8 ± 17.4 Female 
0.33 65.2 ± 29.6 60.2 ± 25.1 Male Total fat (gr) 
0.46 54.1 ± 14.1 50.7 ± 17.7 Female 
0.63 21.9 ± 4.6 20.1 ± 4.1 Male Poly unsaturated fatty 
acid (PUFA)( gr) 0.54 19.3 ± 4.2 18.8 ± 3.8 Female 
0.78 91.2 ± 28.5 88.8 ± 24.1 Male Vitamin C (mg) 
0.55 89.5 ± 26.2 93.3 ± 32.3 Female 
0.17 709.4 ± 230.1 676.6 ± 274.9 Male Vitamin A( µg) 
0.38 755.2 ± 264.1 725.9 ± 210.8 Female 
0.46 9.3 ± 4.0 9.1 ± 3.7 Male Vitamin E (mg) 
0.15 9.2 ± 2.2 8.7 ± 3.0 Female 
0.26 12.9 ± 3.4 13.7 ± 4.1 Male Iron intake (mg) 
0.11 11.0 ± 2.9 12.1 ± 4.0 Female 
0.33 7.75 ± 1.7 8.34 ± 2.1 Male 
Zn intake (mg) 
0.26 6.85 ± 1.8 7.26 ± 2.1 Female 
0.14 1.89 ± 0.4 2.02 ± 0.6 Male 
Cu intake (mg) 
0.09 1.67 ± 0.4 1.81 ± 0.6 Female 
Independent T-test showed no significant difference between the two groups in the two cities 
*n= 78 in Semnan, n=87 in Damgan 
**n=83 in Semnan, n= 82 in Damgan  
  
Based on the results of this part of the study, there was no significant difference 
in iron status and oxidative stress biomarkers at baseline between the study 
groups. 
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5-2   Field trial 
  
Effects of iron fortified flour consumption on iron status and 
oxidative stress in the intervention group and its comparison 
with the control group after 32 weeks 
 
In this part, based on our study design, flour fortification program started only in 
Semnan (intervention city) in its two flour factories after baseline data collection. 
So, the volunteers in this city consumed bread fortified with 30 mg/kg iron but in 
Damgan (control city), usual flour was distributed without any extra iron. We 
followed the volunteers in these two cities for 32 weeks. After 32 weeks, the 
second part of data collection started. The normality of the distribution of the 
variables in the second phase of the study was tested using Kolmogorov-
Smirnov test. To compare the mean of variables between the study groups in 
the two cities at baseline and after 32 weeks, paired t-test was applied.  
The means and standard deviations (SDs) of BMI, systolic, and diastolic blood 
pressure at baseline and after 32 weeks are presented in table 5-2-1 and table 
5-2-2.  
 
Table 5-2-1 Mean and standard deviation of BMI, systolic, and diastolic blood pressure of male 
participants from Semnan and Damgan at the beginning and after 32 weeks 
Males    
(n=60 in Semnan and n=62 in Damgan) 
City Variables 
P value 
After 32 weeks   
Mean(± SD) 
Baseline   
Mean(± SD) 
0.96 26.8 ± 3.7 26.8 ± 3.6 Damgan BMI  ( kg/m2) 0.61 26.8 ± 5.6 26.9 ± 5.2 Semnan 
0.28 119.0 ± 14.0 120.7 ± 12.1 Damgan Systolic blood pressure 
 (mmHg) 0.40 121.0 ± 11.7 119.9 ± 13.2 Semnan 
0.96 78.3  ± 11.3 78.3  ± 11.1 Damgan Diastolic blood 
pressure  (mmHg) 0.95 75.2  ± 13.5 75.3 ± 8.4 Semnan 
   Paired T-test did not show any significant differences among males in the two cities 
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The idea that obesity (BMI ≥ 30 kg/m2) is a state of chronic oxidative stress and 
inflammation, even in the absence of other CVD risk factors, shows the 
importance of developing effective preventions and treatment strategies for 
obesity. While Keaney and colleagues (Keaney et al, 2003) suggest that obesity 
is independently associated with oxidative stress, the close association between 
obesity and other conditions that potentially increase oxidative stress leaves 
open the possibility of residual confounding factors; for example, the association 
between oxidative stress and obesity may be related to other unmeasured 
variables.  
 
Table 5-2-2 Mean and standard deviation of BMI, systolic, and diastolic blood pressure of 
female participants from Semnan and Damgan at the beginning and after 32 weeks 
Females  
 ( n=66 in Semnan and n=62 in Damgan) 
City Variables 
P value 
After 32 weeks   
Mean(± SD) 
Baseline   
Mean(± SD) 
0.13 31.5 ± 6.1 31.3 ± 5.7 Damgan BMI  ( kg/m2) 0.60 30.1 ± 4.1 30.2 ± 4.2 Semnan 
0.16 119.8 ± 15.6 121.7 ± 16.3 Damgan Systolic blood pressure 
 (mmHg) 0.36 118.1 ± 16.9 119.7 ± 15.7 Semnan 
0.26 79.1  ± 10.7 82.1  ± 12.0 Damgan Diastolic blood 
pressure  (mmHg) 0.38 76.0  ± 11.0 78.5  ± 10.6 Semnan 
   Paired T-test did not show any significant differences among females in the two cities 
 
Mean values of BMI, systolic, and diastolic blood pressure of males and 
females in the two cities were constant throughout this part of the study. There 
were no statistically significant differences in BMI, systolic, and diastolic blood 
pressure between the study groups in the two cities at the beginning of the 
study nor they significantly changed after 32 weeks. 
According to literature review, physical activity is one of the main factors that 
induces oxidative stress. Sudden vigorous exercise has been shown to increase 
oxidative stress because increased aerobic metabolism is a source of oxidative 
stress, whereas long-term moderate exercise may upregulate antioxidative 
enzymes and decrease indices of oxidative stress. In order to find differences in 
physical activity, we used the short format of self-administrated International 
Physical Activity Questionnaire (IPAQ). The purpose of the IPAQ is to provide a 
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set of well-developed instruments that can be used internationally to obtain 
comparable estimates of physical activity. Based on this questionnaire, three 
levels of physical activity are proposed: low, moderate, and high. However, to 
summarize data, we just mentioned the percentage of low active and high 
active individuals in our tables. Based on the data on Table 5-2-3 and Table 5-
2-4, there were no significant changes between the study groups at the baseline 
and after 32 weeks. 
 
Table 5-2-3 Physical activity of male participants from the two cities at the beginning and after 
32 weeks 
city 
low active %  High active % 
P value 
Baseline 
After 
32 weeks 
Baseline 
After 
32 weeks 
Damgan 
(n= 62) 57.4 55.1 10.6 10.2 0.9 
Semnan 
(n= 60) 56.0 54.2 12.0 12.5 0.9 
The Chi-square test showed no significant difference between the two groups 
 
The percentage of low active males in Damgan and Semnan at baseline was 
57.4% and 56%, respectively. After 32 weeks, however, it decreased a little in 
Damgan and Semnan to 55.1% and 54.2% respectively, but there was no 
statistically significant difference between them (table 5-2-3). The percentage of 
high active men in Damgan and Semnan at baseline was 10.6% and 12%, 
respectively. Although this rate in Damgan and Semnan changed to 10.2% and 
12.5% respectively, there was no significant difference between them (table 5-
2-3).  
The percentage of low active women in Damgan and Semnan at baseline was 
70.8% and 70.6% respectively which increased to 71.4% and 72.2% after 32 
weeks, respectively; however, the difference was not significant (table 5-2-4). 
The percentage of high active women in Damgan and Semnan at baseline was 
6.3% and 7.8% which decreased to 6.1% and 7.4% after 32 weeks, 
respectively. The difference, however, was not significant (table 5-2-4). 
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Table 5-2-4 Physical activity of female participants from the two cities at the beginning and after 
32 weeks 
city 
Low active % High active % 
P value 
Baseline 
After 
32 weeks 
Baseline 
After 
32 weeks 
Damgan 
(n= 62) 70.8 71.4 6.3 6.1 0.8 
Semnan 
(n= 66) 70.6 72.2 7.8 7.4 0.7 
 The Fisher’s exact test showed no significant difference between the two groups 
 
After 32 weeks of fortified flour consumption in Semnan, in order to investigate 
any significant difference in iron status, we compared the mean and SD of 
hemoglobin, ferritin, serum iron, TIBC, TS, and serum transferrin receptors of 
males and females with baseline values. These data are presented in Table 5-
2-5 and Table 5-2-6. However, the paired t-test did not show significant 
differences. 
The mean value of the parameters related to iron status such as hemoglobin, 
ferritin, serum receptor transferrin, serum iron, TIBC, and transferrin saturation 
in Damgan females worsened after 32 weeks, as presented in table 5-2-5, but 
the difference was not significant. Meanwhile in Semnan, where all subjects had 
consumed fortified bread for 32 weeks, these parameters remained constant or 
rather improved, but there was no significant difference in their parameters, as 
well (table5-2-5). It should be noted that not all subjects in our study were 
anemic. 
Table 5-2-6 shows mean and standard deviation of iron status in male 
participants at baseline and after 32 weeks. Based on the data presented in this 
table, the iron status of men in Semnan is a little better than Damgan but paired 
t-test showed no statistically significant differences. 
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  Table 5-2-5 Mean and standard deviation of iron status and some endogenous antioxidant 
parameters in female participants from Semnan and Damgan at baseline and after 32 weeks 
Females   
( n=66 in Semnan and n=62 in Damgan) City Variables 
P value After 32 weeks  Mean(± SD) 
Baseline  
Mean(± SD) 
 
 
0.39 12.9 ± 0.9 13.0 ± 0.5 Damgan Hemoglobin  (gr/dl) 
0.97 12.8 ± 0.8 12.8 ± 0.7 Semnan 
0.41 96.8 ± 37.5 98.4 ± 40.2 Damgan Ferritin  (ngr/ml) 
0.82 100.8 ± 39.3 98.9 ± 39.7 Semnan 
0.12 1.5 ± 0.6 1.4 ± 0.6 Damgan Serum transferrin 
receptor  (µgr/ml) 0.23 1.3 ± 0.3 1.3 ± 0.4 Semnan 
0.10 86.8 ± 26.5 94.0 ± 31.4 Damgan 
Serum Iron  (µgr/dl) 
0.32 94.9 ± 30.0 90.2 ± 31.1 Semnan 
0.30 297.8 ± 84.0 289.9 ± 76.1 Damgan Total Iron Binding 
Capacity (TIBC) ( µgr/dl) 0.35 289.8 ± 82.0 295.2 ± 72.9 Semnan 
0.18 28.1 ± 7.6 31.9 ± 13.6 Damgan Transferrin Saturation 
(TS) (%) 0.78 29.0 ± 13.4 28.9 ± 12.6 Semnan 
0.08 3.9 ± 0.3 4.0 ± 0.3 Damgan Albumin  (gr/dl) 
0.05  4.1 ± 0.6 3.9 ± 0.3 Semnan 
0.02 0.73 ± 0.21 0.82 ± 0.28 Damgan Total Bilirubin  (µgr/d) 
0.86 0.90 ± 0.32 0.89 ± 0.35 Semnan 
0.12 7.1 ± 0.4 7.2 ± 0.6 Damgan Total protein  (gr/dl) 
0.00 7.3 ± 0.5 7.0 ± 0.4 Semnan 
0.00 4.0 ± 0.9 4.6 ± 1.1 Damgan Uric acid  (mg/dl) 
0.16 4.4 ± 1.0 4.6 ± 1.1 Semnan 
 
 
In Tables 5-2-5 and 5-2-6, some serum antioxidant parameters such as 
albumin, uric acid, total protein, and total bilirubin are also presented. Serum 
albumin (3.9 to 4.1 gr/dl) and total protein (7.0 to 7.3 gr/dl) significantly 
increased in females from Semnan (p<0.05) but in females from Damgan, uric 
acid (4.6 to 4mg/dl) and total bilirubin (0.82 to 0.73µgr/dl) significantly 
decreased (p<0.05). Data also suggested that among males in Semnan, 
albumin (3.9 to 4.1gr/dl) and total protein (7.0 to 7.4gr/dl) significantly increased 
(p<0.05), but total bilirubin (1.11 to 0.89µgr/dl) significantly decreased (p<0.05). 
Meanwhile in Damgan, uric acid (5.3 to 4.9mg/dl) and total bilirubin (1.03 to 
0.89µgr/dl) significantly decreased in males (p<0.05). 
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Table 5-2-6 Mean and standard deviation of iron status and some endogenous antioxidant 
parameters in male participants from Semnan and Damgan at baseline and after 32 weeks 
Males  
(n=60 in Semnan and n=62 in Damgan)     
City Variables P 
value 
After 32 weeks   
Mean(± SD) 
Baseline   
Mean(± SD) 
0.79 14.3 ± 1.1 14.3 ± 0.8 Damgan Hemoglobin  (gr/dl) 
0.40 14.4 ± 0.8 14.3 ± 0.8 Semnan 
0.67 158.1 ± 57.1 157.5 ± 57.9 Damgan Ferritin  (ngr/ml) 
0.70 145.5 ± 45.1 143.5 ± 47.1 Semnan 
0.20 1.4 ± 0.3 1.3 ± 0.3 Damgan Serum transferrin 
receptor  (µgr/ml) 0.65 1.2 ± 0.2 1.2 ± 0.2 Semnan 
0.86 100.0 ± 32.2 100.1 ± 29.7 Damgan Serum Iron  (µgr/dl) 
0.95 101.6 ± 31.5 101.2 ± 29.6 Semnan 
0.62 314.4 ± 73.3 299.3 ± 72.6 Damgan Total Iron Binding 
Capacity (TIBC) ( µgr/dl) 0.71 316.5 ± 66.3 321.2 ± 75.9 Semnan 
0.35 32.0 ± 14.4 34.9 ± 11.7  Damgan Transferrin Saturation 
(TS) (%) 0.36 29.3 ± 11.2 31.2 ± 11.3 Semnan 
0.85 4.0 ± 0.2 4.0 ± 0.3 Damgan Albumin  (gr/dl) 
0.03 4.1 ± 0.5 3.9 ± 0.2 Semnan 
0.004 0.89 ± 0.29 1.03 ± 0.42 Damgan Total Bilirubin  (µgr/d) 
0.007 0.89 ± 0.25 1.11 ± 0.55  Semnan 
0.48 7.1 ± 0.4 7.1 ± 0.4 Damgan Total protein  (gr/dl) 
0.00 7.4 ± 0.6 7.0 ± 0.5 Semnan 
0.00 4.9 ± 0.8 5.3 ± 1.0 Damgan 
Uric acid  (mg/dl) 
0.18 5.1 ± 1.2 4.9 ± 1.1 Semnan 
 
In order to compare mean and SD of oxidative stress parameters of the male 
and female participants after 32 weeks of fortified flour consumption in Semnan 
with Damgan with baseline values, we used MDA, TAC, SOD, GPx, protein 
carbonyl, and Ox-LDL.  
Malondialdehyde (MDA) mean and standard deviation of male and female 
participants are illustrated in table 5-2-7 and table 5-2-8. Although the mean 
value of MDA increased in participants from Semnan (male and female), where 
fortified bread was consumed, paired t-test showed no significant difference in 
this parameter in males and females from Semnan and Damgan after 32 
weeks.  
Mean and standard deviation of participants for TAC at baseline and after 32 
weeks are presented in table 5-2-7 and table 5-2-8. To identify any change 
throughout the study (32 weeks), the paired t-test was used. Although 
participants from Semnan (male and female) experienced a much more 
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decrease in TAC compared to participants from Damgan, these changes were 
not significant after 32 weeks. 
Mean and standard deviation of SOD and GPx at baseline and after 32 weeks 
are shown in table 5-2-7 and table 5-2-8. SOD and GPX are important enzymes 
that protect body against oxidative stress. Although mean values of SOD and 
GPx after 32 weeks of fortified bread consumption increased in participants 
from Semnan compared to the values of the participants from Damgan, paired t-
test showed no statistically significant difference in males and females after 32 
weeks in the two cities. 
 
Table 5-2-7 Comparing means and standard deviations of oxidative stress and dietary 
antioxidants among females at the baseline and after 32 weeks in Semnan and Damgan 
Females  
 ( n=66 in Semnan and n=62 in Damgan) 
City Variables  
P value 
After 32 weeks   
Mean(±SD) 
Baseline   
Mean(±SD) 
0.46 2.7 ± 0.8 2.8 ± 1.0 Damgan 
Malondialdehyde MDA   (µmol/L) 
0.48 3.0 ± 0.9 2.9 ± 1.1 Semnan 
0.64 1.79 ± .10 1.83 ± 0.25 Damgan Total antioxidant capacity TAC   
(µmol/L) 0.41 1.80 ± 0.12 1.86 ± 0.18 Semnan 
0.31 0.55 ± 0.14 0.58 ± 0.23 Damgan Superoxide dismutase SOD  
(U/ml) 0.17 0.63 ± 0.17 0.55 ± 0.25 Semnan 
0.84 180.6 ± 64.0 183.5 ± 35.5 Damgan Glutathione Peroxidase GPx  
 ( U/ml/min) 0.72 183.7 ± 57.2 181.4 ± 31.8 Semnan 
0.23 2.14 ± 0.69 2.26 ± 0.59 Damgan 
Protein carbonyl  (nmol/mg) 
0.46 2.31 ± 1.64 2.25 ± 0.54 Semnan 
0.59 180.7 ± 64.0 188.9 ± 81.0 Damgan Oxidized LDL  (µmol/L) 
0.28 215.4 ± 99.0 198.4 ± 61.5 Semnan 
0.03 61.02 ± 19.7 73.2 ± 24.4 Damgan 
Vitamin A  (µgr/dl) 
0.02 62.7 ± 18.2 73.1 ±24.0 Semnan 
0.83 1.51 ± 0.53 1.49 ± 0.52 Damgan 
Vitamin E  (mg/dl) 
0.70 1.55 ± 0.42 1.52 ± 0.56 Semnan 
0.23 58.3 ± 25.0 53.1 ± 19.5 Damgan Lycopene  (µgr/dl) 
0.10 73.2 ± 26.5 64.3 ± 26.4 Semnan 
0.02 34.7 ± 13.5 26.8 ± 13.3 Damgan 
β-carotene  (µgr/dl) 
0.01 37.8 ± 17.1 26.5 ± 12.7 Semnan 
 
Mean values of protein carbonyl and oxidized LDL are shown in table 5-2-7 
and table 5-2-8. Both of these oxidative stress biomarkers increased in 
participants from Semnan (both male and female) after 32 weeks of fortified 
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bread consumption, but paired t-test showed no significant difference in men 
and women after 32 weeks compare with baseline values. 
 
Table 5-2-8 Mean and standard deviation of oxidative stress and dietary antioxidants in male 
participants from Semnan and Damgan at baseline and after 32 weeks 
Males           
(n=60 in Semnan and n=62 in Damgan) 
City Variables 
P value 
After 32 weeks   
Mean ± SD 
Baseline   
Mean ± SD 
0.63 2.9 ± 0.8 2.9 ± 1.1 Damgan Malondialdehyde MDA   (µmol/L) 
0.16 3.2 ± 0.8 3.0 ± 0.9 Semnan 
0.12 1.83 ± 0.20 1.87 ± 0.24 Damgan Total antioxidant capacity TAC   
(µmol/L) 0.08 1.76 ± 0.16 1.82 ± 0.21 Semnan 
0.24 0.54 ± 0.1 0.58 ± 0.2 Damgan Superoxide dismutase SOD  
(U/ml) 0.12 0.63 ± 0.1 0.59 ± 0.2 Semnan 
0.58 180.2 ± 63.1 174.6 ± 35.3 Damgan Glutathione Peroxidase GPx  
(U/ml/min) 0.06 196.8 ± 62.2 178.2 ± 39.2 Semnan 
0.23 2.13 ± 0.15 2.29 ± 0.27 Damgan Protein carbonyl  (nmol/mg) 
0.38 2.28 ± 0.18 2.22 ± 0.26 Semnan 
0.41 179.9 ± 85.2 181.8 ± 61.6 Damgan Oxidized LDL  (µmol/L) 
0.60 190.5 ± 60.8 185.1 ± 64.2 Semnan 
0.01 64.0 ± 13.1 73.3 ± 26.1 Damgan Vitamin A  (µgr/dl) 
0.00 65.6 ± 16.4 78.6 ± 22.6 Semnan 
0.17 1.46 ± 0.54 1.33 ± 0.51 Damgan Vitamin E  (mg/dl) 
0.20 1.45 ± 0.37 1.39 ± 0.43 Semnan 
0.39 53.8 ± 20.9 50.0 ± 21.0 Damgan Lycopene  (µgr/dl) 
0.06 64.2 ± 22.8 57.5 ± 21.8 Semnan 
0.00 39.3 ± 16.2 25.0 ± 12.1 Damgan 
β-carotene  (µgr/dl) 
0.00 37.6 ± 18.3 27.9 ± 14.1 Semnan 
 
 
Mean and standard deviation of the serum levels of vitamin A, vitamin E, 
lycopene, and beta carotene for male and female participants are illustrated in 
table 5-2-7 and table 5-2-8. These tables show that mean and SD of vitamin A 
and β-carotene significantly decreased (p<0.05) and increased (p<0.05) 
respectively after 32 weeks in male and female participants from the two cities. 
Paired t-test showed no significant difference in vitamin E and lycopene serum 
levels of male and female participants from Semnan and Damgan after 32 
weeks compared to the baseline. 
The total intake of energy, macronutrients, iron, zinc, copper, and antioxidant 
vitamins of male and female participants at baseline and after 32 weeks are 
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presented in table 5-2-9 and table 5-2-10. Except for the iron intake that 
significantly increased among males and females in Semnan after 32 weeks, 
paired t-test did not show any significant difference during the study (32 weeks) 
in the intake of these parameters.  
 
Table 5-2-9 Energy, macronutrients, iron, zinc, copper, and antioxidant vitamins intake of the 
male participants from Semnan and Damgan at baseline and after 32 weeks 
Males  
(n=78 in Semnan, n=87 in Damgan) 
City Variables 
P value 
After 32 weeks  
Mean(± SD) 
Baseline  
Mean(± SD) 
0.06 2257.5 ± 502.6 2166.3 ± 488.6 Damgan Energy (kcal) 
0.67 2158.5 ± 600.3 2207.7 ± 652.8 Semnan 
0.56 65.0 ± 16.0 65.4 ± 15.4 Damgan Protein (gr) 
0.63 65.7 ± 24.0 66.9 ± 21.5 Semnan 
0.74 61.3 ± 25.0 59.5 ± 24.7 Damgan Total fat (gr) 
0.70 63.3 ± 24.1 66.7 ± 21.0 Semnan 
0.44 20.3 ± 4.7  19.4 ± 4.2  Damgan Poly unsaturated fatty 
acid (PUFA)( gr) 0.83 22.9 ± 5.2 22.3 ± 4.9   Semnan 
0.69 95.4 ± 25.5 88.6 ± 23.0 Damgan Vitamin C (mg) 
0.62 93.2 ± 28.3 90.5 ± 26.1 Semnan 
0.85 661.1 ± 235.0 659.9 ± 297.7 Damgan Vitamin A( µg) 
0.38 680.5 ± 220.4 690.5 ± 235.0 Semnan 
0.28 9.6 ± 3.1 9.1 ± 3.4 Damgan Vitamin E (mg) 
0.07 10.4 ± 2.9 9.2 ± 3.5 Semnan 
0.63 13.3 ± 3.8 13.7 ± 4.3 Damgan Iron intake (mg) 
000 15.8 ± 6.0 12.9 ± 3.1 Semnan 
0.43 8.76 ± 2.4 8.34 ± 2.1 Damgan 
Zn intake (mg) 
0.38 7.71 ± 1.9 7.75 ± 1.8 Semnan 
0.24 1.98 ± 0.7 2.11 ± 0.6 Damgan 
Cu intake (mg) 
0.29 1.82 ± 0.4 1.87 ± 0.4 Semnan 
Except for iron intake, paired t-test did not show any significant differences between the two 
groups of the study.   
 
Mean and SD of vitamin C and vitamin E (powerful antioxidants), are presented 
in tables 5-2-9 and 5-2-10. Mean intake of both vitamins increased after 32 
weeks in all participants of Semnan and Damgan but this increase was not 
statistically significant. The RDA of vitamin C for non-smoker adult males and 
females is 75 and 90 mg/day, respectively. Recommended dietary allowance for 
vitamin E (alpha-tocopherol) for adults is 15 mg/day. 
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Table 5-2-9 indicates that the mean intake of vitamin C in females from Semnan 
and Damgan was more than 90 mg/day which is 20% more than RDA. 
However, the mean intake of vitamin E in male and female participants from 
Semnan and Damgan was less than 70% of RDA. It can be concluded that 
males and females from Semnan and Damgan do not take adequate amounts 
of vitamin E per day. 
Table 5-2-10 Energy, macronutrients, iron, zinc, copper, and antioxidant vitamins intake of 
female participants from Semnan and Damgan at baseline and after 32 weeks 
Females  
(n=83 in Semnan, n=82 in Damgan) 
City Variables 
P value 
After 32 weeks  
Mean(± SD) 
Baseline  
Mean(± SD) 
0.34 1685.5 ± 469.5 1550.8 ± 532.6 Damgan Energy (kcal) 
0.96 1672.5 ± 404.5 1685.1 ± 455.0 Semnan 
0.86 50.1 ± 14.7 50.8 ± 18.7 Damgan Protein (gr) 
0.48 50.2 ± 13.9 52.9 ± 16.6 Semnan 
0.88 52.3 ± 18.8 52.4 ± 27.5 Damgan Total fat (gr) 
0.29 50.2 ± 15.5 52.9 ± 22.9 Semnan 
0.73 17.3 ± 3.7 18.2 ± 4.0 Damgan Poly unsaturated fatty 
acid (PUFA)( gr) 0.12 16.1 ± 3.6 19.1 ± 4.5 Semnan 
0.65 97.0 ± 33.0 91.9 ± 33.1 Damgan Vitamin C (mg) 
0.82 94.4 ± 24.2 90.6 ± 25.5 Semnan 
0.91 707.4 ± 283.9 714.7 ± 299.5 Damgan Vitamin A( µg) 
0.82 692.2 ± 258.5 686.6 ± 271.0 Semnan 
0.28 8.9 ± 3.1 8.3 ± 3.1 Damgan Vitamin E (mg) 
0.15 8.8 ± 3.0 8.1 ± 3.6 Semnan 
0.34 12.6 ± 3.3 12.1 ± 3.9 Damgan Iron intake (mg) 
000 15.3 ± 4.8 11.1 ± 2.8 Semnan 
0.78 7.38 ± 2.0 7.33 ± 2.2 Damgan 
Zn intake (mg) 
0.82 6.89 ± 1.9 6.70 ± 1.8 Semnan 
0.18 1.94 ± 0.6 1.89 ± 0.6 Damgan Cu intake (mg) 
0.27 1.70 ± 0.4 1.74 ± 0.5 Semnan 
Except for iron intake, paired t-test did not show any significant differences between two 
groups of the study  
 
Zinc and copper were also important in our study because except for their 
specific role in oxidative stress, they compete with iron for absorption or 
intestinal uptake. Recommended dietary allowance for zinc for adult males and 
females is 11 and 8 mg, respectively. RDA for copper (Cu) is 900 µgr/day. 
Based on the data presented in tables 5-2-9 and 5-2-10, it can be stated that 
zinc intake of female participants is much better than male participants, but Cu 
intake of both males and females in our study were two times more than RDA. 
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As mentioned earlier, paired t-test did not show any statistically significant 
differences in these micronutrients between males and females in our study 
after 32 weeks compared to the baseline.      
The total intake of iron in male and female participants from Semnan and 
Damgan are presented in tables 5-2-9 and 5-2-10. Mean iron intake in male and 
female participants from Semnan increased significantly which was the result of 
fortifying flour with 30 mg/kg iron in Semnan for 32 weeks. After starting flour 
fortification, we measured the iron content of flour regularly (as explained in 
QA/QC) in flour samples which were taken from bakeries in Semnan and 
Damgan. Mean iron levels of flour at baseline in Semnan and Damgan were 
29.8 and 31.8mg/kg, respectively. The mean iron values in Semnan and 
Damgan were 61.6 and 33.5 mg/kg throughout the 32 weeks of flour 
fortification. Based on the iron content of flour in Semnan, which was 
satisfactory (40-65.9 mg/kg as good level), we can conclude that flour 
fortification program was successfully implemented in Semnan during the study.  
 
According to the results of this part of the study, paired t-test showed no 
statistically significant difference in iron status and oxidative stress biomarkers 
between the study groups after 32 weeks of implementing the flour fortification 
program in Semnan compared to Damgan.      
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5-3   Before and after study 
 
Effects of iron fortified flour consumption on iron status and 
oxidative stress after 64 weeks in Semnan 
 
As mentioned earlier, the governor did not permit us to keep Damgan (control 
group) without fortification for more than 32 weeks, so we had to start flour 
fortification in this city. For this reason, in the second part of the study, we did 
not have Damgan as the control group and therefore, we continued flour 
fortification with iron in Semnan for 32 weeks again. This part of the study was a 
before and after study which was conducted in Semnan for 64 weeks. Data 
collection was done after 64 weeks of starting flour fortification in Semnan for 
the third time. 
 
Mean and SD of BMI, systolic, and diastolic blood pressure in the three phases 
of the study, i.e. baseline, after 32 weeks and after 64 weeks, were compared 
within each group (table 5-3-1). Mean values of BMI, systolic, and diastolic 
blood pressure of the participants were constant throughout the study for all 
participants in the two groups. The ANOVA did not show any statistically 
significant differences in BMI, systolic, and diastolic blood pressure in the three 
phases of the study within each group (table 5-3-1).  
Mean BMI of females was around 30.3 kg/m2 which indicated that females in 
our study were overweight or even obese. Compared to females, mean BMI of 
males was around 26.5 kg/m2 which showed that most of the men had a normal 
weight. Based on our data, females in our study were more at risk of oxidative 
stress than males.  
Although mean BMI of the female participants was above normal (BMI between 
20 and 25 is defined as normal), their systolic and diastolic blood pressure were 
around 116 and 78 mmHg respectively that is close to the normal range (The 
latest medical thinking assumes that a blood pressure of 120 over 80 is the 
midpoint of the "normal" range). 
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Table 5-3-1 Means and standard deviation of BMI, systolic, and diastolic blood pressure of male 
and female participants from Semnan at the beginning, after 32 weeks, and 64 weeks 
Semnan 
53 Males and 51 Females 
Sex Variables 
P value 
After   
64 weeks  
Mean ± SD 
After   
32 weeks  
Mean ± SD 
Baseline  
Mean ± SD 
0.99 30.3 ± 4.4 30.3 ± 4.3 30.3 ± 4.4 Female BMI  ( kg/m2) 0.98 26.7 ± 5.6 26.5 ± 5.8 26.5 ± 5.5 Male 
0.97 116.4 ± 11.5 116.3 ± 17.2 116.9 ± 14.1 Female Systolic blood pressure  
(mmHg) 0.16 119.2 ± 12.9 115.3 ± 11.9 119.8 ± 13.5 Male 
0.47 78.3 ± 8.2 77.6  ±10.9 78.6 ± 9.6 Female Diastolic blood pressure  
(mmHg) 0.67 76.8 ± 10.7     75.3 ± 14.3 75.4 ± 8.9 Male 
The ANOVA did not show significant changes in male and female from Semnan 
  
Table 5-3-2 shows physical activity in both sex groups in Semnan. To compare 
physical activity in males and females in this part of study, we used the short 
self- administrated version of IPAQ.  
 
Table 5-3-2 Physical activity of males and females at the beginning, after 32 weeks, and after 
64 weeks in Semnan 
P value 
High active  % active  % Low 
Sex After  
64 weeks 
After  
32 weeks Baseline 
After  
64 weeks 
After  
32 weeks Baseline 
0.7 7.4 7.4 7.8 70.4 72.2 70.6 
Female 
(n=51) 
0.9 10.4 12.5 12.0 54.2 54.2 56.0 
Male 
(n=53) 
 
In Semnan, similar to most parts of Iran, women are less active than men and 
they spend most of their time indoors. However, males were more physically 
active than females in our study. Regular physical activity has a low priority to at 
least half of Iranian men. Those aged between 30 and 50 years are often not 
very physically active because they are busy with work and family 
commitments. Lack of physical activity results in a range of health problems 
including obesity, heart disease, and some forms of cancer. Based on our data, 
there was no significant difference in regarding physical activity at the 
beginning, after 32 weeks, and after 64 weeks of the study between males and 
females. 
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Mean and SD of iron status including hemoglobin, ferritin, serum iron, TIBC, TS, 
and serum transferrin receptors in all participants at baseline, after 32, and 64 
weeks are compared in Table 5-3-3. In this table, except for serum iron of the 
male participants, ANOVA did not show any significant differences in other 
parameters related to iron status at baseline, after 32 weeks (second phase), 
and after 64 weeks (third phase).  
Although mean values of hemoglobin and ferritin increased after 32 and 64 
weeks of fortified flour consumption in male and female participants, these 
changes were not significant (table 5-3-3). The trend of these variables was 
positive which indicated that with a longer duration of flour fortification, 
significant changes of these variables would be possible. 
Serum transferrin receptor (sTfR) concentration has been recently recognized 
as a reliable indicator of functional iron deficiency. During this study the amount 
of serum transferrin receptor was constant, indicating that fortified flour 
consumption for even 64 weeks or about 8 months had no effects on this 
precious parameter among non-anemic adults.  
Male participants experienced a significant increase in the mean value of serum 
iron, which describes the concentration of iron (bound to transferrin) in serum, in 
the third phase (after 64 weeks of fortified flour consumption).  
Female participants also experienced an increase in serum iron values after 32 
and 64 weeks of the study, but the change was not statistically significant. 
Significant changes of serum iron in males may be because males ate fortified 
bread more than females.  
Mean TIBC values of males and females in the second and third phase were 
nearly constant, and there were no obvious changes during the course of the 
intervention in males and females. 
Mean percentage of transferrin saturation (TS) was another parameter of iron 
status in this study. Comparing values at baseline, in the second phase (after 
32 weeks), and the third phase (after 64 weeks) showed that there was an 
increase in the percentage of TS in both males and females during the study. 
Although ANOVA showed no significant difference between the study groups, 
the positive trend of TS in the second and third phase showed that transferrin 
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saturation was increasing. So, if fortification continued for a longer period, 
significant changes would possible.  
  
 
Table 5-3-3 Mean and standard deviation of iron status and serum endogenous antioxidant in 
male and female participants from Semnan at baseline, after 32 weeks and after 64 weeks 
Semnan  
53 Male and 51 Female  
Sex Variables 
P value 
After  
 64 weeks 
Mean ± SD 
After   
32 weeks 
Mean ± SD 
Baseline  
Mean ± SD 
0.33 13.2 ± 0.9
 
12.8 ± 0.7 12.8 ± 0.6 Female Hemoglobin  (gr/dl) 
0.14 14.5 ± 0.8 14.3 ± 0.8 14.2 ± 0.7 Male 
0.72 104.8 ± 35.0 104.0 ± 52.0 98.0 ± 43.9 Female Ferritin  (ngr/ml) 
0.10 168.0 ± 40.3 146.1 ± 72.8 143.0 ± 65.0 Male 
0.87 1.3 ± 0.46 1.3 ± 0.40 1.3 ± 0.34 Female Serum transferrin receptor  
(µgr/ml) 0.79 1.2 ± 0.4 1.1 ± 0.5 1.2 ± 0.5 Male 
0.50 97.1 ± 26.2 94.5 ± 29.5 90.5 ± 29.4 Female Serum Iron  (µgr/dl) 
0.00 117.2 ± 29.8
ab 
109.7 ± 31.6 102.9 ± 31.5 Male 
0.52 295.8 ± 49.6 299.1 ± 83.0 301.4± 75.6 Female Total Iron Binding Capacity 
(TIBC) ( µgr/dl) 0.43 332.9 ± 37.3 320.8 ± 64.8 327.1 ± 78.8 Male 
0.87 29.2 ± 8.5 28.6 ± 8.4 28.3 ± 9.9 Female Transferrin Saturation (TS) 
(%) 0.32 33.8 ± 8.8 31.5 ± 10.5 30.5 ± 9.3 Male 
000 5.0 ± 0.3
ab 
4.1 ± 0.6 4.0 ± 0.3 Female Albumin  (gr/dl) 
000 5.1 ± 0.4
ab 
4.2 ± 0.4 3.9 ± 0.3 Male 
0.10 0.82 ± 0.16
 
0.92 ± 0.34 0.85 ± 0.32 Female Total Bilirubin  (µgr/d) 
0.05 0.93 ± 0.23 0.87 ± 0.23
a
 1.11 ± 0.48 Male 
000 7.8 ± 0.7
ab 
7.3 ± 0.6 7.0 ± 0.4 Female Total protein  (gr/dl) 
000 7.7 ± 0.7
a 
7.4 ± 0.6 6.9 ± 0.5 Male 
0.53 4.3 ± 1.1
 
4.4 ± 1.1 4.6 ± 1.1 Female Uric acid  (mg/dl) 
0.85 5.0 ± 1.1 5.1 ± 1.2 5.0 ± 1.2 Male 
a: compared with the first phase, b: compared with the second phase 
 
Mean and SD of albumin, total bilirubin, uric acid, and total protein in the three 
phases of the study were compared within each group (table 5-3-3). ANOVA did 
not show significant changes in uric acid throughout the study for males and 
females but showed a significant difference in serum albumin of the subjects 
within each group at the three intervals of the study. In order to compare the 
third phase with the second and the first phase, multiple comparisons using 
Bonferroni and Dunnett post-hoc tests were utilized. Multiple comparisons 
showed that mean values of albumin at the third phase in both male and female 
participants significantly increased when compared to the second and the first 
phase (p<0.001).  
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Total protein significantly increased (p<0.001) in females in the third phase 
(after 64 weeks), compared to the second (32 weeks) and the first phase 
(baseline). In males, this increase was only significant when comparing the third 
phase (after 64 weeks) with the first phase (baseline).  
Albumin comprises about half of the blood serum protein. Significant changes of 
total protein and albumin at the third phase confirm each other. 
ANOVA did not show any statistically significant differences in total bilirubin in 
females. However, ANOVA showed significant changes in total bilirubin in 
males when comparing the first phase with the second phase (baseline and 
after 32 weeks). 
Mean and SD of oxidative stress biomarkers (including; MDA, TAC, SOD, GPx, 
PC, Ox-LDL) at baseline, after 32 weeks and after 64 weeks are presented in 
table 5-3-4. ANOVA showed that in males, mean TAC decreased and mean 
SOD and GPX increased significantly after 64 weeks (p<0.05). ANOVA did not 
show significant changes in these parameters after 64 weeks in females. 
Comparing the mean values of MDA and Oxidized-LDL at baseline with the 
second phase (after 32 weeks) and the third phase (after 64 weeks) showed 
that there was an increase in the amount of MDA and Oxidized-LDL in both 
males and females. Although this increase was not significant, it indicated that if 
flour fortification continued for a longer time, significant changes in these 
parameters would probable. 
Mean and SD of TAC in males decreased in the second (after 32 weeks) and 
the third phase (after 64 weeks) of the study. Multiple comparisons showed that 
the decrease of TAC was only significant when the third phase was compared 
with the first phase.   
Comparing TAC values of females in third phase with the second and the first 
phase was also interesting. TAC values of females in the first and the second 
phase was constant but decreased after 64 weeks of fortified flour consumption. 
ANOVA did not show any significant differences in mean TAC of the female 
participants at the three intervals of the study.  
73 
 
Mean values of SOD and GPx for both males and females are illustrated in 
table 5-3-4. The values of these two oxidative stress parameters, which are 
important enzymes in protecting body from oxidants, increased in the second 
(after 32 weeks) and the third phase (after 64 weeks) of the study in both 
genders. ANOVA showed that the changes in SOD and GPx were statistically 
significant only in males (p<0.02 for SOD, p<0.04 for GPx) which was related to 
the amount of these parameters in the third phase (after 64 weeks) as shown in 
the table 5-3-4. In fact, multiple comparisons showed that there were no 
significant differences in SOD and GPx mean values in the second and the first 
phase in males and females. 
Mean and SD of protein carbonyl (PC) at the three intervals of the study are 
presented in table 5-3-4 as well. ANOVA showed no significant differences in 
PC between groups at baseline, after 32 weeks, and after 64 weeks of fortified 
flour consumption. The mean values of PC at the third phase decreased 
insignificantly when compared to the second phase of the study in males and 
females.    
Mean and SD of serum vitamin E, Lycopene, β-carotene, and vitamin A are also 
presented in table 5-3-4. ANOVA showed no statistically significant differences 
in lycopene between groups in the three phases of the study but showed that 
mean serum levels of vitamin A in both genders decreased significantly in the 
three phases of the study (p<0.05) (table 5-3-4).  
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Table 5-3-4 Mean and standard deviation of oxidative stress and dietary antioxidants in male 
and female participants from Semnan at baseline, after 32 weeks, and after 64 weeks 
Semnan  
53 Males and 51 Females 
Sex Variables 
P value 
After  
64weeks  
Mean ± SD 
After   
32 weeks  
Mean ± SD 
Baseline  
Mean ± SD 
0.48 3.2 ± 0.7 3.0 ± 1.0 2.9 ± 1.1 Female Malondialdehyde,   
MDA   (µmol/L) 0.36 3.2 ± 0.7 3.1 ± 0.8 3.0 ± 1.0 Male 
0.18 1.73  ±  0.10 1.77 ± 0.12 1.77 ± 0.16 Female Total antioxidant capacity, 
TAC   (µmol/L) 0.01 1.71 ±  0.10a 1.78 ± 0.14 1.83 ± 0.17 Male 
0.07 0.65 ± 0.12
   
0.63 ± 0.10
 
0.55 ± 0.25 Female Superoxide dismutase ,  
SOD  (U/ml) 0.02 0.67 ± 0.12a 0.62 ± 0.10 0.56 ± 0.24 Male 
0.11 194.1 ± 59.1
 
193.7 ± 50.8
 
181.4 ± 48.1 Female Glutathione Peroxidase, 
GPx  (U/ml/min) 0.04 200.0 ± 46.7a 192.0 ± 49.3 176.6 ± 38.1 Male 
0.48 2.34 ± 1.27
  
2.37 ± 1.34
 
2.23 ± 0.51 Female Protein carbonyl ,   
PC (nmol/mg) 0.33 2.18 ± 1.2 2.27 ± 1.4 2.21 ± 0.58 Male 
0.31 226.9 ± 89.0 215.0 ± 87.8 199.1 ± 64.1 Female Oxidized LDL  (µmol/L) 
0.50 201.0 ± 70.6 193.6 ± 65.0 185.1 ± 64.2 Male 
000 58.7 ± 19.3
a 
63.0 ± 23.1
a 
72.7 ± 24.0 Female Vitamin A  (µgr/dl) 
000 62.8 ± 14.1
a 
66.0 ± 16.4
a 
78.6 ± 22.6 Male 
0.90 1.57 ± 0.4 1.55 ± 0.4 1.53 ± 0.6 Female Vitamin E  (mg/dl) 
0.01 1.64 ± 0.4
a 
1.46 ± 0.3 1.39 ± 0.4 Male 
0.31 64.5 ± 24.8 72.0 ± 26.5 64.1 ± 35.9 Female Lycopene  (µgr/dl) 
0.11 66.4 ± 19.4 64.0 ± 22.6 57.5 ± 21.9 Male 
0.03 35.6 ± 18.8 38.5 ± 23.7
a 
27.3 ± 18.9 Female 
β-carotene  (µgr/dl) 
0.02 38.8 ± 16.2
a 
36.5 ± 16.5
 
28.8 ± 13.3 Male 
a: compared with the first phase, b: compared with the second phase 
 
The mean values of serum vitamin E in study groups as shown in table 5-3-4 
increased in the three phases of the study but this increase was only significant 
among males (p<0.05).   
Male participants experienced a significant increase in mean values of serum β-
carotene in the three phases of the study (p<0.05). For females, however, the 
difference was significant when the second phase was compared with the first 
phase.  
The total intake of energy, macronutrients, iron, zinc, copper, and antioxidant 
vitamins in male and female participants at baseline, after 32 weeks, and after 
64 weeks of implementing flour fortification are presented in table 5-3-5. Except 
for iron intake, ANOVA showed no statistically significant difference between 
groups in the three phases of the study.  
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Mean total energy intake of males and females in this part of the study was 
nearly constant; however, it decreased insignificantly in the third phase. 
Comparison between baseline and the third phase (after 64 weeks fortified flour 
consumption) showed that there was an increase in the amount of total protein 
intake in both genders (table 5-3-5). There was a decrease in the amount of 
total fat intake as well. The amount of PUFA decreased in females while it 
increased in males. The mean intake of vitamin C increased in both genders at 
the end of the study compared to the baseline. Mean values of vitamin A in 
females increased insignificantly.  
 
Table 5-3-5 Energy, macronutrients, iron, zinc, copper, and antioxidant vitamins intake of males 
and females at the baseline, after 32, and 64 weeks in Semnan 
  
Semnan  
53 Males and 51 Females Sex Variables 
P value 
After   
64 weeks  
Mean ± SD 
After   
32 weeks  
Mean ± SD 
Baseline  
Mean ± SD 
0.93 1660.8 ± 456.6 1677.5 ± 424.5 1693.1 ± 460.0 Female Energy (kcal) 
0.67 2177.3 ± 705.1 2164.5 ± 600.3 2207.7 ± 652.8 Male 
0.58 53.0 ± 15.9 51.2 ± 13.9 52.7 ± 16.3 Female Protein (gr) 
0.35 72.1 ± 23.8 63.7 ± 24.0 65.7 ± 20.6 Male 
0.76 53.4 ± 24.5 51.2 ± 15.5 53.9 ± 21.5 Female Total fat (gr) 
0.66 68.5 ± 22.3 64.3 ± 22.1 69.7 ± 23.2 Male 
0.32 18.2 ± 4.1 16.4 ± 3.6 19.3 ± 4.5 Female Poly unsaturated 
fatty acid (PUFA)( gr) 0.42 25.8 ± 5.4 23.9 ± 5.2 22.8 ± 4.9   Male 
0.53 98.7 ± 27.7 95.4 ± 25.2 92.6 ± 27.5 Female Vitamin C (mg) 
0.62 97.5 ± 30.1 92.2 ± 28.3 89.5 ± 27.1 Male 
0.82 682.8 ± 223.4 689.2 ± 248.5 680.6 ± 273 Female Vitamin A( µg) 
0.28 671.5 ± 225 687.5 ± 223 694.5 ± 238 Male 
0.15 9.9 ± 2.3 9.5 ± 3.3 8.8 ± 3.7 Female Vitamin E (mg) 
0.25 10.9 ± 3.9 10.6 ± 2.9 9.3 ± 3.2 Male 
000 14.7 ± 4.0 15.5 ± 4.3 11.3 ± 2.9 Female Iron intake (mg) 
000 15.6 ± 5.0 15.4 ± 5.9 12.5 ± 3.1 Male 
0.33 6.72 ± 1.7 6.94 ± 1.8 6.81 ± 1.8 Female Zn intake (mg) 
0.56 7.71 ± 1.9 7.78 ± 2.0 7.83 ± 1.9 Male 
0.44 1.69 ± 0.5 1.72 ± 0.5 1.77 ± 0.6 Female Cu intake (mg) 
0.65 1.81 ± 0.4 1.86 ± 0.5 1.91 ± 0.4 Male 
 
 
Mean intake of vitamin E increased in both genders at the third phase (after 64 
weeks). The mean intake of zinc (Zn) and copper (Cu) decreased in males and 
females at the end of study or after 64 weeks of consuming fortified flour. None 
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of the above-mentioned changes were statistically significant in the three 
phases of the study (baseline, after 32 weeks and after 64 weeks). 
As a result of consuming fortified bread in Semnan during the study, the total 
mean intake of iron increased in study groups. ANOVA showed statistically 
significant differences (p<0.01) in males and females in the three phases of 
study (table 5-3-5). 
As mentioned earlier, one of the main parts of our study was QA/QC to monitor 
flour fortification with iron. For this reason, regular flour samples from three 
factories and bakeries of Semnan were collected and sent them to an 
accredited laboratory to measure the iron content of flour.  
For the process evaluation, we first measured the iron content of flour samples 
from two factories in Semnan after fortification (Omide Semnan and 
Ardvasabose Semnan).  
Mean iron level of flour during the first 32 weeks of flour fortification was 54.6 
mg/kg in 39 samples from Omide Semnan and 57.8 mg/kg in 33 samples from 
Ardvasabose Semnan. During the second 32 weeks of flour fortification, the 
mean level of iron was 57.9 mg/kg in 29 flour samples from Omide Semnan and 
60.1 mg/kg in 31 flour samples from Ardvasabose Semnan. These iron levels 
are defined as ‘good’ (40-65.9 mg/kg). 
Table 5-3-6 shows iron distribution in flour samples obtained from bakeries 
during the study. This table shows the exact amount of iron in flour based on 
spectrophotometric measurements. According to this table, flour fortification 
was successfully implemented in Semnan. 
Table 5-3-6 Iron content (mg/kg) of flour samples obtained from bakeries at baseline, within the 
first 32 weeks, and within the second 32 weeks of the study 
City 
Baseline 
Median(IQR) 
Within first 32 weeks  
Median(IQR) 
Within second 32 weeks 
Median(IQR) 
Semnan 29.8 (9.10) 
n=32 
61.6 (13.8) 
n=29 
59.6 (12.9) 
n=28 
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  6 DISCUSSION 
6-1 Baseline characteristics of the subjects 
 
In the present study, at baseline, there was no significant difference in age, 
BMI, systolic and diastolic blood pressure between males and females in two 
cities. Mean BMI of males was nearly in the normal range in both cities but 
women had a mean BMI of more than 30 kg/m2 which is categorized as obese. 
However, obesity was a very important concern in our study. Independent t-test 
showed no significant difference in women in the two cities. Obesity can 
independently influence the results and can act as a confounding factor.  
Gender is a significant effect modifier in the association between adiposity and 
oxidative stress. The reasons for different results between genders regarding 
adiposity and oxidative stress are not clear and require additional investigation. 
 
Physical activity is also a significant effect modifier in the association between 
adiposity and oxidative stress. Results of this part showed that women are less 
active than men but there was no statistically significant difference within each 
gender at the start of the study. 
 
One of the recent studies on the association between obesity and oxidative 
stress is a cross sectional study by Charles et al (Charles et al, 2008).  In this 
study, adiposity measures and oxidative stress were evaluated among police 
officers. This study included randomly selected police officers (43policewomen; 
67 policemen) from Buffalo, New York. Officers were 26- to 61-years old. 
Adiposity measures were evaluated using standardized methods. Biomarkers 
were measured on fasting blood specimens. An oxidative stress score (OSS) 
was created as a composite of the biomarkers. Results of this study showed 
that GPx was inversely associated with BMI (trend p = 0.004) and with waist-to-
height ratio (trend p = 0.017). The results of this study showed that adiposity 
was significantly associated with several markers of oxidative stress and lower 
antioxidant defense. 
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In another study by Amirkhizi et al (Amirkhizi et al, 2007), the hypothesis that 
obesity increases plasma lipid peroxidation and decreases erythrocyte 
cytoprotection was tested. In this study, 160 obese women (BMI=30-40 Kg/m2) 
aged 20-45 years were randomly selected. The concentration of plasma MDA 
was significantly higher (P<0.001) in obese women compared to women with 
healthy BMI. Furthermore, there was a significantly positive correlation (r =0.75, 
P<0.0001) between BMI and plasma MDA. On the other hand, women with a 
healthy BMI had a significantly higher (P<0.001) erythrocyte SOD and GPX 
activity than obese women. Furthermore, erythrocyte SOD and GPX activity 
was negatively correlated with BMI (r =-0.52, P<0.0001 and r =-0.42, P<0.001), 
respectively. No significant difference was observed between the two groups in 
erythrocyte CAT activity. It is concluded that obesity, even in the absence of 
smoking, diabetes, renal or liver diseases, can decrease the activity of body’s 
protective antioxidants, and can enhance the systemic oxidative stress. 
  
We did not find any significant changes in energy, protein, fat, and other 
relevant nutrient intakes in participants at the baseline of the study. At the three 
intervals (baseline, after 32 weeks, after 64 weeks) a 3-day 24-hour dietary 
recall and quantitative food frequency questionnaire were completed for each 
participant by a trained nutritionist. Quantities were estimated from photographs 
of portion sizes and from household measures (Ghafarpour et al, 2007). 
Participants were instructed to maintain their usual dietary habits throughout the 
study. Monthly follow-ups were performed by phone.  
 
Bread is a staple food in Iran and the mean intake of bread in Semnan is about 
300gr/day. Flour fortification, when appropriately implemented, does not 
significantly affect the organoleptic qualities (color, smell or taste) of foods such 
as cakes, breads, and noodles. Therefore, flour fortification and fortified bread 
consumption in the diet of the subjects did not change their dietary habits. 
There were no significant differences in iron status and oxidative stress 
biomarkers at the baseline of the study. It is possible that by introducing fortified 
bread to the diet of subjects, changes in iron status or consequently oxidative 
stress ensue. 
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6-2 The first hypothesis 
 
Flour fortification program does not cause iron overload in healthy 
non-anemic adults after 32 and 64 weeks 
 
Iron overload is defined as the accumulation of iron in the body due to any 
cause. Iron overload is a serious chronic condition that must be properly 
diagnosed and treated. Undiagnosed iron overload can lead to 
hemochromatosis, which is potentially life-threatening.  
Transferrin saturation and serum ferritin were used to determine iron overload in 
our study. 
In this regard, ferritin levels more than 200 ng/ml for female subjects and more 
than 300 ng/ml for male subjects and transferrin saturation higher than 55% for 
both genders were considered as iron overload.  
In table 6-2-1, the number of the subjects that were diagnosed with iron 
overload based on both ferritin and transferrin saturation in Semnan are 
presented. The following table (table 6-2-1) even shows that the number of iron 
overload subjects did not changed during the study and the change in the rates 
is just due to the decrease of the number of the participants in the second (after 
32 weeks) and the third (after 64 weeks) phase of the study.  
Regarding the results in table 6-2-1, there were no significant changes in ferritin 
and transferrin saturation in men and women. Therefore, flour fortification did 
not cause iron overload after 32 and 64 weeks.  
Fortifying flour with iron has been used as an efficient and inexpensive 
approach for reducing the prevalence of iron deficiency in many countries. 
However, this method has been abolished, even in some developed countries, 
due to the probable negative effects of iron overload (Olssen et al, 1997).  
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Table 6-2-1 The number of iron overload subjects out of total number of each 
groups based on ferritin more than 200 ng/ml for women and more than 300 
ng/ml for men and transferrin saturation more than 55 % for both sex in Semnan   
sex Baseline 
Num (out of) 
 
After 32 weeks 
Num (out of) 
 
After 64 weeks 
Num (out of) 
 
Female 
3 (78) 
3.8% 
3 (60) 
5% 
3 (53) 
5.6% 
Male 4 (83) 
4.8% 
4 (66) 
6.1% 
4 (51) 
7.8% 
 
In the recent 10 years, several studies have been done on this issue but 
unfortunately, their results are not complete and do not yield a clear conclusion. 
For example, although the relationship between serum ferritin and the risk of 
cardio-vascular diseases has been reviewed in at least 14 studies, result of a 
meta-analysis could not definitely confirm the relationship (Danesh and 
Appleby, 1999). 
Concerns regarding the negative effects of iron have been raised after 
considerable progresses were made in recognizing iron metabolism and its role 
in developing active oxygen (Hentze et al, 2004). The highest tolerable iron 
intake is 45 mg/day (Allen et al, 2006). Although it is nearly impossible to reach 
this level by adding 30 mg iron to one kg of flour, there is evidence of appearing 
iron related disorders with even lower doses in the long term (Rehema et al, 
1998).   
Because of continuous blood transfusions, thalassemia patients are prone to 
peroxidative tissue injury through secondary iron overload. In a study by Livrea 
et al (Livrea et al, 1996), oxidative stress in thalassemia patients was 
investigated. In this study, analysis of serum from 42 β-thalassemia patients, 
aged 4 to 40 years, showed that the mean concentrations of MDA, PC, and 
conjugated diene increased about twofold compared to the control. Ferritin 
levels were positively correlated with the amount of MDA (r = 0.41; p= 0.007) 
and showed a positive trend with protein carbonyl (r = 0.35; p= 0.07) as further 
evidence for deleterious effects of high tissue iron levels. The total serum 
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antioxidant capacity also significantly decreased by 14%. Serum levels of 
vitamin E were inversely correlated with ferritin (r =- 0.45; p=0.003), suggesting 
a major consumption of this antioxidant under iron overload. These results 
suggested that iron-induced liver damage in thalassemia may play a major role 
in depleting lipid-soluble antioxidants. 
In a study by Day (Day et al, 2003) on mice, giving 15 mg/day iron to mice 
parenterally for 6 weeks caused iron overload and increased the production of 
ROS, and the incidence of cardio-vascular diseases. Although the relationship 
between iron overload and cardio-vascular diseases in animals cannot be 
generalized to humans with certainty, the results of this study showed the 
specific role of iron in developing cardio-vascular diseases and thrombosis. 
 Although in studies by livrea (Livrea et al, 1996) and Day (Day et al, 2003), a 
close relationship was reported between iron intake or injected iron and iron 
overload, it seems that our study is more similar to Hallberg’s study which 
concluded that iron overload was not probable if fortified foods were consumed 
due to the change of iron absorption proportionate to the amount of iron intake 
(Hallberg et al, 1997) (Hallberg et al, 2002). 
 
One of the noticeable and similar studies to our research is a study by Rehema 
et al (Rehema et al, 1998). In this study, effects of long-term alimentary 
(drinking water) iron overload on the parameters of oxidative stress were 
evaluated. The study group (n = 35) from a village in southern Estonia was 37.1 
± 13.3 years old, and the mean period of drinking water iron overload was 20.6 
± 9.3 years. Daily consumption of alimentary iron was 25±10mg, 10±4mg of that 
from drinking water. Results of this study showed that the mean value of serum 
iron was significantly higher than normal. The total iron-binding capacity of 
serum tended to lower. The parameters of lipid peroxidation, such as 
conjugated dienes and thiobarbituric acid reactive substances, also significantly 
increased (p<0.001). The total antioxidant capacity of serum did not change. It 
can be concluded that long-term alimentary iron overload results in a positive 
serum iron balance which in turn increases oxidative stress. 
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The similarity of our study with this study is in the absence of anemia and iron 
deficiency in subjects. Moreover, the amount of iron was similar to our study (9 
mg/day in our study compared to 10 mg/day in Rehema’s study) but Rehema's 
study was continued for a longer period (20 years) than ours (64 weeks or 
about 16 months). However, it is not clear whether Rehema reached the same 
results if the duration of the study was shorter. As we used the same amount of 
daily iron intake as Rehema did, it could be concluded that long-term flour 
fortification results in iron overload in non-anemic healthy individuals.  
Evidence suggests that high iron intake and high levels of iron store are risk 
factors of cardio-vascular diseases and cancer. 
In this study, transferrin and ferritin as markers of detecting iron overload did not 
show iron overload in participants after 32 and 64 weeks of intervention but 
there was a positive trend in nearly all parameters of iron status which is 
suggestive of increased iron retention in the body. Therefore, it is possible that 
consuming fortified bread by non-anemic individuals for a longer period causes 
iron overload as a result of increased iron retention.  
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 6-3 The Second hypothesis 
Consuming Iron fortified flour does not induce oxidative stress 
biomarkers in the study population after 32 and 64 weeks 
 
This hypothesis is divided into two parts: 
 
6-3-1 Consuming Iron fortified flour does not induce oxidative stress 
biomarkers in the study population after 32 weeks 
 
6-3-2 Consuming Iron fortified flour does not induce oxidative stress 
biomarkers in the study population after 64 weeks 
 
 
6-3-1 Consuming Iron fortified flour does not induce oxidative stress 
biomarkers in the study population after 32 weeks: 
This part of the study was done through a field trial. After baseline data 
collection, flour fortification started with 30 mg/kg iron in Semnan. Based on 
mean bread consumption in Semnan (300 gr/day), 9 mg iron was added to their 
daily food baskets. So, subjects of Semnan (intervention group) consumed 
bread baked with fortified flour for 32 weeks (about 8 months) while subjects of 
Damgan (control group) consumed bread with non-fortified flour in this period.  
It should be noted that since different kinds of breads are baked in these two 
cities, for ensuring the consumption of iron fortified bread by all subjects of 
Semnan, all bakery flour of this city was fortified during the study. Meanwhile, in 
addition to continuous monitoring of the iron content of the fortified flour, the 
research team regularly collected flour samples from bakeries of Semnan and 
Damgan and sent them to an accredited laboratory for determining their iron 
content. The results showed that the bread baked in Semnan was fortified and 
the bread baked in Damgan was not fortified and did not contain the added 
amounts of iron. Also, tables 5-2-9 and 5-2-10 show that fortification program 
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significantly increased the iron content of consumed bread of the male and 
female participants of Semnan (p<0.001) during the study. The iron intake of 
the male and female participants of Damgan did not significantly change in this 
period. These findings show that the flour fortification program was successfully 
implemented in Semnan (intervention group).  
In the field trial part of our study, after 32 weeks of fortified flour consumption, 
mean values of hemoglobin, ferritin, serum iron, TIBC, TS, and serum 
transferrin receptor did not show any statistically significant differences between 
the study groups in Semnan compared to Damgan. Comparing changes in the 
mean differences of oxidative stress biomarkers such as MDA, TAC, SOD, 
GPx, protein carbonyl, and oxidized-LDL in Semnan and Damgan also did not 
show any significant differences.   
In some studies, in which iron was given to the subjects, some oxidative stress 
biomarkers significantly changed.  
In a double-blind randomized clinical trial study by Khoshfetrat et al (Khoshfetrat 
et al, 2008), oxidative stress indices were compared between iron deficient and 
healthy subjects. In this study, 60 non-anemic iron deficient and 30 healthy 
female students were selected. After matching, non-anemic iron deficient 
students were randomly assigned into two groups receiving 50 mg/day 
elemental iron with and/or without 500 mg/day ascorbic acid for 12 weeks. At 
the end of the study, serum TAC significantly increased in supplemented 
subjects, not only compared to the baseline values (within group) but also in 
comparison with controls (between groups) (p<0.001). The mean MDA 
concentration in the group receiving both iron and vitamin C was significantly 
less than group receiving iron alone. It seems that iron supplementation with 
ascorbic acid can decrease the oxidative stress so it can be recommended for 
more efficient control of iron deficiency. 
In a clinical randomized trial by Amirkhizi (Amirkhizi et al, 2006), effects of iron 
supplementation on lipid peroxidation among iron deficient women aged 20 to 
45 year were investigated. In this study, 38 non-anemic iron deficient and 36 
healthy women were randomly selected. Iron supplementation consisting of 120 
mg ferrous sulfate (50 mg elemental iron) was given to iron deficient non-
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anemic women. Results of this study showed that iron supplementation 
increased lipid peroxidation and also decreased total antioxidant capacity.  
   
Amirkhizi et al (Amirkhizi et al, 2008) investigated any relationship between 
body iron stores with levels of oxidative stress in another study. The results 
showed that subjects in the highest tertile of plasma ferritin had the highest 
levels of plasma MDA (p<0.001) and catalase activity (p<0.05). These findings 
revealed an association between body iron stores and oxidative stress markers. 
In spite of the studies that showed the positive correlation between iron and 
oxidative stress, there are a few studies that have failed to show any significant 
effect of iron on oxidative stress.    
In a study by Gropper et al (Gropper et al, 2003), giving 50 mg iron to non-
anemic iron deficient girls for two months improved their iron status and 
increased their iron reserves but did not affect oxidative stress indicators 
significantly. Also, Binkoski et al (Binkoski et al, 2003) in a study showed that 
iron supplementation in iron deficient women improved their iron status without 
increasing their oxidative stress. In this study, giving 100mg/day iron to healthy 
and iron deficient women for eight weeks enhanced their serum ferritin status 
but did not change their oxidative stress indicators significantly. The difference 
between studies by Binkoski and Gropper and our study is that our intervention 
time was longer but the amount of iron intake in our study was much less than 
those two studies (50mg/day iron in the study by Gropper et al and 100mg/day 
iron in the study by Binkoski et al compared to 9mg/day iron in our study). 
Iron deficiency does not only affect the production of hemoglobin, but also the 
production of other proteins containing Fe2+ such as cytochromes, myoglobin, 
catalase, and peroxidase. The extracellularly generated O2•- and H2O2 have 
been shown to traverse erythrocyte membranes. Impairment of antioxidant 
defense system and reduced cellular immunity and myeloperoxidase activity 
were previously reported in patients with iron deficiency anemia. All of these 
factors may contribute to inadequate erythrocyte survival. 
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Erythrocytes are excellently equipped to handle intracellular oxidative stress 
through combined activities of superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPx), and glutathione (GSH). However, the protective 
efficiency of erythrocytes against lipid peroxidation and carbonylation depends 
on the balance between oxidant species and the availability of antioxidant 
defenses. Literature offers contradictory and limited data on oxidative stress 
and antioxidant defenses in patients with iron deficiency anemia. 
In a study by Kurtoglu et al (Kortoglu et al, 2003), the effect of iron 
supplementation on antioxidant status in iron-deficient anemia, including the 
time for hemoglobin normalization and at the time of filling iron body stores was 
measured. The extent of plasma lipid peroxidation was evaluated by measuring 
the levels of malondialdehyde and glutathione peroxidase (GPx), and the 
activity of superoxide dismutase (SOD) and catalase in 63 patients with iron-
deficiency anemia before and after 6 weeks of iron supplementation and when 
body iron stores were saturated. After 6 weeks of iron supplementation, a 
significant decrease in oxidative stress was observed in the treated subjects 
compared to controls (p<0.05). No significant difference existed between 
treated patients after 6 weeks and at the end of the study. The erythrocyte 
levels of catalase, SOD, and GPx were significantly lower in treated patients 
compared to controls (p<0.05). These levels increased after 6 weeks of 
supplementation (p<0.05) and showed no significant difference with the values 
at the end of the study. These results indicated that iron supplementation did 
not induce oxidative stress. It was also concluded that to evaluate the oxidative 
stress and iron supplementation, time is important. 
 
Appropriate adjustment of iron absorption from the digestive system and 
inhibiting the entrance of surplus iron can be other reasons mentioned in the 
study by Hallberg et al (Hallberg et al, 1997). Hallberg et al showed the effect of 
ferritin on inhibiting iron absorption from the digestive system and even 
mentioned that in amounts of ferritin higher than 60ng /ml, iron absorption from 
the digestive system decreased and therefore, in iron fortification programs, 
increase of the iron absorption is not a concern.  In our study, the average of 
ferritin in both genders was higher than 60ng/ml that is completely compatible 
with the results of the Hallberg's study. However, it is still debated whether the 
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ability of human body in controlling iron absorption can persist for a long time. 
This question is partly answered in the next part of our study. 
 
 
The reason why no significant changes were observed in iron status and 
oxidative stress after 32 weeks of fortified flour consumption within each gender 
could be that our participants were non-anemic and healthy people. The second 
reason could be the iron doses which were several times more than the amount 
which was in our study.  
Time is also important, positive trend in some oxidative stress biomarkers such 
as SOD, GPx, protein carbonyl, and oxidized-LDL can be the first step of 
significant changes if flour fortification continues for a longer duration. 
Totally, according to results of our field trial and comparing them with the results 
of other studies, implementing flour fortification for 32 weeks does not have any 
adverse effects on oxidative stress indicators and iron status among non-
anemic healthy men and women. 
 
6-3-2 Consuming Iron fortified flour does not induce oxidative stress 
biomarkers in the study population after 64 weeks: 
If we had Damgan as the control group for the second 32 weeks too, our study 
would be more comprehensive. Due to the objection of the governor and other 
authorities of Semnan province to postponing flour fortification in Damgan, we 
had to start this program in Damgan. 
In order to study the effects of flour fortification for 64 weeks, flour fortification 
was continued for another 32 weeks in Semnan and data of the third phase 
(after 64 weeks) of Semnan was compared with the information of the first 
phase as a before and after study.  
After testing the normal distribution of variables by Kolmogrov-Smirnov test, 
one-way ANOVA was used for comparing averages among different groups. 
Multiple comparisons among phases were done with the Bonferroni and 
Dunnett post-hoc tests. It should be noted that the volunteers who had 
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participated in the first phase of the study, participated in the second and third 
phases too (the target population was paired before and after intervention).   
To study the changes in oxidative stress indicators, undertaking the correct 
process of flour fortification program in Semnan had to be ensured in the first 
step. In fact, we had to make sure that flour fortification program was well-
implemented and based on the determined objectives in the second 32 weeks 
in Semnan. In this regard, during the second phase of the study, twenty eight 
flour samples from bakeries in Semnan were analyzed. The median (IQR) iron 
concentration of flour was 61.6 (13.8) mg/kg, which was defined as ‘good’ (40-
65.9 mg/kg). Also sixty five flour samples from two flour factories (Omid 
Semnan and Ardvasaboose Semnan) in Semnan were analyzed by Central 
Food and Nutrition Lab (CFNL). Mean (±SD) iron level of flour was 54.7 (11.2) 
mg/kg, which was defined as ‘good’. 
The amount of iron in flour and bread showed the successful implementation of 
fortification program in Semnan and it was indicated that the program was 
successfully implemented until the end of the study.  
The mean and SD of iron status and oxidative stress biomarkers were 
measured after 64 weeks. Although the trend of haemoglobin, ferritin, and 
transferrin saturation was positive in both genders, except for serum iron in 
male participants, ANOVA did not show any statistically significant differences 
in the rest of iron status parameters in the three phases of the study in males 
and females (table 5-3-3). 
Also, among oxidative stress biomarkers, male participants experienced a 
significant change in mean serum levels of SOD (p<0.001) and GPx (p<0.05) 
activity in third phase (after 64 weeks) compared to baseline (table 5-3-4). The 
positive and significant correlation between serum iron and SOD in male 
subjects of Semnan was seen in the third phase of the study, too (p<0.05, r = 
0.249). 
Heinecke et al (Heineke et al, 1984) in an in vivo study on smooth muscle cells 
derived from explants of human aorta showed that Fe and Cu content of the 
incubation medium profoundly influenced modification of LDL by human arterial 
smooth muscle cells. Modification, as assessed by the increase in thiobarbituric 
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acid reacting substances (TBARS) and in electrophoretic mobility, was 
promoted by micromolar concentrations of either Fe or Cu. 
Carrier et al (Carrier et al, 2002) designed a study to determine whether oral 
iron supplementation in rats with dextran sulfate sodium (DSS)-induced colitis 
increased intestinal inflammation and oxidative stress and whether the addition 
of an antioxidant, vitamin E, reduced this detrimental effect. Results of this 
study showed that oral iron supplementation significantly enhanced disease 
activity in rats with DSS-induced colitis which was associated with an increase 
in oxidative stress. Vitamin E, a potent antioxidant, did not reduce lipid 
peroxidation but significantly reduced intestinal inflammation and disease 
activity, even with concurrent iron supplementation. 
In a population-based case-control study by Kallianpur et al (Kallianpur et al, 
2008) the effects of iron and fats from various food sources on the risk of breast 
cancer were investigated. In this study, 3452 breast cancer cases, and 3474 
age-frequency matched controls completed an in-person interview including a 
detailed food-frequency questionnaire. Results of this study showed that a high 
intake of animal-derived iron (heme iron) might be associated with an increased 
risk of primary breast cancer in Chinese women, and saturated and mono-
unsaturated fats derived from animal sources might augment this effect. 
In another study by Bae et al (Bae et al, 2009), the relationship between iron 
and oxidative stress, as potential risk factors, and the development of breast 
cancer (BC) was investigated. BC patients (n = 121) and healthy age-matched 
controls (n = 149) entered the study. Iron and antioxidant vitamins intakes were 
estimated using a quantitative food frequency questionnaire. This study showed 
that total and non-heme iron intake of BC patients were lower than those of the 
controls. However, the serum iron level was significantly higher in BC patients. 
Plasma MDA levels were also significantly higher in BC patients. These results 
suggested that serum iron overload could be a breast cancer risk factor, 
possibly due to increased oxidative stress. 
 
Epidemiological evidence concerning the role of iron, a lipid peroxidation 
catalyst, in coronary heart disease (CHD) is inconsistent. Tuomainen 
90 
 
(Tuomanain et al, 1998) investigated the association between the concentration 
ratio of serum transferrin receptor to serum ferritin (TfR/ferritin) and the risk of 
acute myocardial infarction (AMI). In this prospective nested case-control study 
on eastern male Finns, results showed an association between increased body 
iron stores and increased risk of AMI, confirming previous epidemiological 
findings. 
 
Ferritin is a 24 subunit protein composed of two subunit types, termed H and L. 
the ferritin H subunit has a potent ferroxidase activity that catalyses the 
oxidation of ferrous iron, whereas ferritin L plays a role in iron nucleation and 
protein stability. The H subunit is thought to play a role in rapid detoxification of 
iron. Orino et al (Orino et al, 2001) in a study using HeLa cells, immoral cells 
used in scientific researches, reported that synthesis of both subunits of ferritin 
in HeLa cells exposed to oxidative stress significantly increased (p<0.05). They 
observed that overexpression of either ferritin H or ferritin L reduced the 
accumulation of ROS in response to oxidant challenge. 
In a prospective cohort study to assess the association between breast cancer 
and total iron and heme iron intake, Kabat et al (Kabat et al, 2007) used data 
from a large cohort study on Canadian women. In this study, among 49654 
women aged 40-59 who were followed for an average of 16.4 years, they 
identified 2545 incidents of breast cancer. Data from a food frequency 
questionnaire administrated at baseline was used to calculate total dietary iron 
and heme iron intake. The results of this study offered no support for an 
association between iron or heme iron intake and breast cancer risk.  
Although several in-vivo and in-vitro and animal studies have shown the effect 
of iron intake on oxidative stress indicators (Heinecke et al, 1984), (Carrier et al, 
2002), there are few human studies in this regard. While some studies have 
shown negative effects of iron on oxidative stress biomarkers and incidence of 
some kinds of cancers and the risk of acute myocardial infarction (Tuomainen et 
al, 1998), (kallianpour et al, 2008), (Bae et al, 2009), other studies have shown 
the positive role of iron and its related factors such as ferritin, on human body 
(Orino et al, 2001), (Kabat et al, 2007).  
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It should be noted that regarding the importance and the specific role of iron in 
anemic individuals and the necessity of controlling anemia for preventing its 
adverse outcomes, side effects of iron supplements in developing oxidative 
stress are usually ignored. Also, most of the studies have focused on the 
positive effects of fortification programs, and the negative probable aspects of 
such programs which are effective in controlling and preventing micronutrient 
deficiencies have been usually ignored. 
Also in several studies, the relationship between the level of iron stores and 
oxidative stress has been shown (Lasheras et al, 2003) (Amirkhizi et al, 2006), 
(Choi et al, 2008). These studies have indicated that the amount of iron stores 
and levels of plasma iron have a positive and significant relationship with the 
increase of fat peroxidation and oxidative stress. In the most recent of these 
studies, Choi et al in a nested case-control study showed that high iron intake 
can increase oxidative stress in body which in turn increases the risk of prostate 
cancer.  
Age is also an important factor in antioxidant defence status and there is a 
positive relationship between age and oxidative stress status (Prashant et al, 
2007). 
Lack of change in oxidative stress indicators in female subjects can be related 
to their enhanced physiologic ability in facing oxidative stress. This ability has 
been shown in the studies of Vina (Vina et al, 2005), Drog (Drog et al, 2002) 
and Borras (Borras et al, 2003). This ability has been widely studied and 
different reasons have been presented for it. In the studies of Borras and Vina, 
it has been stated that the mitochondria of females has a specific ability for 
producing less amounts of ROS so that males produce ROS two times more 
than females. In another study, this ability of females has been proposed to be 
a genetic specification (Vina et al, 2005). Some authors have related this finding 
to the specific role of estrogen as a strong antioxidant (Ruiz-Larrea et al, 1997) 
(Borras et al, 2005).   
From the results of the two mentioned parts of our study, it can be concluded 
that although iron intake through flour fortification program did not affect 
oxidative stress indicators after 32 weeks (8 months), significant changes of 
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serum iron and also significant changes of some oxidative stress indicators after 
64 weeks (16 months) of implementing flour fortification program implies that 
this program has some side-effects in the long term. In fact, we cannot say flour 
fortification with iron does not induce oxidative stress among non anemic 
apparently healthy adults (males) after 64 weeks.  
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7 CONCLUSION 
There are reports on the effect of the supplements of iron on developing 
oxidative stress and developing cancer. Meanwhile, some studies have not 
confirmed this effect and even reported the specific mechanisms for controlling 
surplus iron in the body.   
Our field trial results confirmed primary phases of oxidative stress and even it 
was significant after a longer period of flour fortification in our before and after 
study. This can be an alarm for the programmers to bear in mind that although 
using this approach is useful for overcoming anemia, plans to prevent its 
adverse effects and to control the fortification program at different levels must 
be devised. In fact, not all the flour should be fortified and non-fortified bread 
should be always accessible to those who have an appropriate iron status. 
Clinical practice and public health policy should be based on reasonably sound 
evidence that what is being recommended is both safe and effective. Given the 
results concerning the iron hypothesis to date, there is no doubt about the 
recommendations. Although further researches, including basic researches and 
large-scale epidemiologic studies, are needed to fully assess the association 
between iron status in flour fortification program and the risk of oxidative stress, 
current data support iron-oxidative stress hypothesis. 
 
7-1 Recommendations 
- Reconsidering the level of iron in the flour fortification program. 
- Strengthening continuous monitoring of the program in the country 
- Not fortifying all the flour that is to be distributed in the society 
- Performing a similar study in other age groups 
- Performing a similar study with longer period of follow-up 
- Giving useful information to the community where flour fortification programs 
are installed  
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8 SUMMARY 
Despite the advantages of fortifying flour with iron, there are still special 
concerns regarding the possible adverse effects of the extra iron taken by non-
anemic individuals in the general population. Furthermore, there are limited 
studies regarding the effects of flour fortification with iron on oxidative stress. 
This study aimed to investigate the effects of fortifying flour with iron on 
oxidative stress biomarkers and iron status in non-anemic 40- to 65-year-old 
adults. 
This study had two parts: the first part was a randomized field trial and the 
second part was a before and after study. Among 31 provinces in the Islamic 
Republic of Iran, Semnan with a low prevalence of anaemia and iron deficiency 
was selected. Among the cities of this province, Damgan and Semnan were 
randomized as control and intervention cities, respectively. In the field trial, 393 
non-anemic apparently healthy male and female volunteers from Semnan and 
Damgan were randomly selected. Data gathering was performed in three 
stages including baseline, after 32 weeks and after 64 weeks. Anthropometric 
measurements, 3-day 24-hour recall, Food Frequency Questionnaire, and 
fasting blood samples were collected at the three stages. Following the first 
stage, flour fortification program started only in Semnan with 30 mg/kg iron as 
ferrous sulphate and all participants were followed for 32 weeks. Evaluation of 
oxidative stress using serum levels of malonedialdehyde (MDA), total 
antioxidant capacity (TAC), super oxide dismutase (SOD), Glutathione 
Peroxidase (GPx) activity, protein carbonyl, and oxidised-LDL as well as the 
assessment of iron status and endogenous and dietary antioxidants were done 
in all three stages.  
In the second part of the study (before and after), as flour fortification started in 
Damgan, we just followed up flour fortification in Semnan to investigate the 
effect of this program in a longer period (64 weeks). 
Results showed that there were no statistically significant changes in iron status 
and oxidative stress biomarkers after 32 weeks of consuming fortified flour in 
Semnan compared to Damgan (Field trial).  
95 
 
Results in the before and after study showed that among iron status 
parameters, serum iron levels in men significantly increased compared to 
baseline values (p<0.001).  Among oxidative stress biomarkers, mean TAC 
significantly decreased (p<0.001), and SOD and GPx significantly increased 
(p<0.05) compared to the baseline values only in men. No clinical symptoms of 
iron overload were observed after 32 and 64 weeks. 
Consumption of iron-fortified flour altered certain antioxidant defense 
biomarkers indicating induced oxidative stress in non-anemic men after 64 
weeks. Our findings do not guarantee the safety of flour fortification with 30 
mg/kg of iron as a community-based approach to control iron deficiency in non-
anemic healthy individuals. Regular amounts of daily flour consumption, burden 
of iron deficiency, regular monitoring, and the safe amount of iron to be added 
to flour must be taken into consideration before implementing iron fortification in 
a population.  
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9 ZUSAMMENFASSUNG 
Trotz der Vorteile der Eisenanreicherung von Mehl, gibt es Bedenken bezüglich 
möglicher nachteiliger Effekte einer zusätzlichen Eisenaufnahme bei nicht-
anämischen Individuen in der allgemeinen Bevölkerung. Außerdem gibt es nur 
wenige Studien die sich mit den Auswirkungen einer Eisenanreicherung des 
Mehls auf den oxidativen Stress befassten. Ziel der Studie war die Erforschung 
des Effekts einer Anreicherung von Mehl mit Eisen auf den Eisenstatus und auf 
Biomarker des oxidativen Stress bei nicht-anämischen Erwachsenen im Alter 
zwischen 40 und 65 Jahren. 
Die Studie gliedert sich in zwei Abschnitte; der erste Teil war ein randomisierter 
Feldversuch und der zweite Teil beschreibt die Situation vor und nach der 
Intervention. Aus 31 Provinzen der islamischen Republik Iran wurde die Provinz 
Semnan ausgewählt, in der niedrige Prävalenzen für Anämie und Eisenmangel 
vorherrschen. Aus den Städten dieser Provinz wurden Damgan als Kontroll- 
und Semnan als Interventionsstadt randomisiert ausgewählt. Für den 
Feldversuch wurden 393 gesunde Freiwillige beider Geschlechter aus den 
Städten Semnan und Damgan randomisiert ausgewählt. Die Datenerfassung 
erfolgte an drei Zeitpunkten: zu Beginn, nach 32 Wochen und nach 64 Wochen. 
Dabei wurden jeweils anthropometrische Messungen, 24-h recalls über 3 Tage, 
Food Frequency Questionnaires und Nüchternblutproben erhoben. Nach der 
ersten Messung wurde die Anreicherung in Form von Eisen(II)-sulfat 
ausschließlich in Semnan gestartet. Zu allen drei Zeitpunkten wurden der 
Eisenstatus und der oxidative Stress anhand der Serumlevels von MDA, TAC, 
SOD, GPx, Proteincarbonyl und oxidiertem LDL ermittelt. 
Im zweiten Teil der Studie (davor und danach), wurde die in Semnan 
durchgeführte Anreicherung beobachtet um deren Langzeiteffekte (64 Wochen) 
zu erforschen. 
Die Ergebnisse zeigten, dass es in Semnan 32 Wochen nach dem Konsum von 
angereichertem Mehl, verglichen mit Damgan keine statistisch signifikanten 
Unterschiede bezüglich Eisenstatus und Biomarkern für den oxidativen Stress 
gab. 
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Ein vorher-nachher-Vergleich zeigte für die Eisenlevels im Serum bei Männern 
einen signifikanten Anstieg (p<0.001). Unter den Biomarkern für den oxidativen 
Stress nahm TAC signifikant ab (p<0.001), während SOD und GPx, verglichen 
mit der Basismessung, bei Männern signifikant zunahmen (p<0.05). Weder 
nach 32, noch nach 64 Wochen traten klinische Symptome einer Überbelastung 
mit Eisen auf. 
Der Konsum von eisenangereichertem Mehl veränderte bestimmte Biomarker 
der antioxidativen Abwehr die ausdrücken, dass es bei nicht-amämischen 
Männern nach 64 Wochen zu einem oxidativen Stress kam. Die gewonnenen 
Erkenntnisse unterstützen den Ansatz einer populationsbezogenen 
Eisenanreicherung mit 30 mg/kg um einen Eisenmangel bei nicht-anämischen 
gesunden Personen vorzubeugen nicht. Täglicher, ausreichender Konsum von 
Eisen, das Vorherrschen von Eisenmangel, regelmäßiges Monitoring und die 
sichere Menge die dem Mehl hinzugefügt werden soll, müssen in Betracht 
gezogen werden, bevor eine Eisenanreicherung auf Bevölkerungsebene 
realisiert wird. 
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Appendices  
NUTRITION DEPARTMENT, UNIVERSITY OF VIENNA, AUSTRIA  
 
 
The effect of flour fortification with iron on oxidative stress 
biomarkers and iron status among non anemic adult  
40-65 years old 
 
Letter of consent 
 
I …..  , declare my agreement for contributing in the researching project of "The 
effect of flour fortification with iron on oxidative stress biomarkers and iron 
status…".In this regard, I will answer the questions of researchers precisely and 
honestly. The goals of this project have been explained to me and I understand 
that for implementing the biochemical tests of this project, 10-12 milliliter fasting 
blood will be taken from me in each of the three steps of project, and in each 
step, my blood sample will be divided in two parts, so that one part will be used 
for determining anemia (I will be referred to a physician in case of anemia), and 
the other part will be used for doing complimentary and also oxidative stress 
tests. Obviously, all of the costs of tests and transporting for samplings will be 
taken over by researchers and the sponsoring organization of this project. I 
understand that contributing in this study may have no advantage for me, but it 
can be useful for enhancing nutritional and health status of my compatriots, and 
also for national health programming and policy making. In spite of this, I have 
the right of stopping my cooperation in this project in every time, and I can sue it 
if any physical or mental damage is made to me. The project administrator 
guarantee confidentiality of my information and all tests will be free of charge for 
me, and a copy of all my tests results will be delivered to me too. 
Mr./Mrs.…………..with phone number……………is ready to answer my 
questions about this project during the project time. 
 
Signature and date: 
 
 
 
 
Address of home: 
Home phone number: 
Address of work place: 
Work place number: 
Mobile phone number: 
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NUTRITION DEPARTMENT, UNIVERSITY OF VIENNA, AUSTRIA  
 
 
The effect of flour fortification with iron on oxidative stress biomarkers 
and iron status among non anemic adult  
40-65 years old 
 
Index  
Information form 
Date:                           ID code:                Number in cluster:                  Number 
of cluster: 
Name and surname:                                                 City: 
1- Age: …..       years 
2- Gender… 
3- Weight:….Kg 
4- Height:…cm 
5- BMI:…kg/m2 
6- Literacy:       Illiterate ¬           Primary school  ¬             Secondary school  ¬    
                    Graduated from high school ¬         Academic education ¬ 
7- Have you consumed iron supplement during last two months? 
Yes, regularly ¬                          Yes, but irregularly ¬                        No ¬ 
8- Do you consume multivitamin supplements? 
 Yes, regularly ¬                          Yes, but irregularly ¬                        No ¬ 
9- Have you had any surgical operation during last two months?   Yes ¬             No ¬ 
10- Are you going to undertake any surgery during the following year? Yes ¬        No ¬ 
11- Do you smoke?  Yes ¬        No ¬ 
12- How many cigarettes do you smoke daily?  …. 
13- How many years have you been smoking?  …. 
14- Does anybody smoke in your home?  Yes ¬        No ¬ 
15- Have you had any febrile disease during last month? Yes ¬        No ¬ 
16- Do you have any specific disease (with diagnosis of a physician)?  
No ¬          Yes ¬   name of disease……              
17- Do you consume alcohol? Yes, regularly ¬         Yes, but irregularly ¬              No¬ 
18- Amount of alcohol consumption/ day? ….. 
19-Have you donated blood during last month? Yes ¬        No ¬ 
20-which drugs do you consume under medical prescription? .... 
22-Blood pressure: 
First time …..mmHg          Second time…… mmHg            Third time ….mmHg 
 
Address of home: 
Home phone number: 
Address of work place: 
Work place number: 
Mobile phone number: 
 
 
Name of questioner:                              signature:             date: 
 
Name of controller:                                signature:             date: 
 
 
 
 
 
111 
 
NUTRITION DEPARTMENT, UNIVERSITY OF VIENNA, AUSTRIA  
 
 
The effect of flour fortification with iron on oxidative stress 
biomarkers and iron status among non anemic adult  
40-65 years old 
 
24hour recall 
 
 
Date:                           ID code:                Number in cluster:                  Number of 
cluster: 
 
Name and surname:                                                 City: 
ingestion period Food Food 
components 
Index and 
amount of 
food 
Breakfast 
 
 
   
between-meal 
       foods 
   
Lunch 
 
 
 
   
between-meal 
       foods 
   
Dinner 
 
 
 
   
between-meal 
       foods 
   
 
 
 
Name of questioner:                              signature:             date: 
 
Name of controller:                                signature:             date: 
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NUTRITION DEPARTMENT, UNIVERSITY OF VIENNA, AUSTRIA  
 
The effect of flour fortification with iron on oxidative stress biomarkers and iron status 
among non anemic adult  
40-65 years old 
 
Food Frequency Questionnaire (FFQ) 
 
Date:                           ID code:                Number in cluster:                  Number of 
cluster: 
 
Name and surname:                                                 City: 
unit Index 
Consumption per 
Never Food No. 
year month week day 
 
Spatula(usual, full), Plat       Rice 1 
 Palm size(number)      Barbari bread 2 
 Palm size(number)      White Bread 3 
 Palm size(number      Lavash bread 4 
 Palm size(number)      Sangak bread 5 
 Palm size(number)      Dry bread of Semnan 6 
 Palm size(number)      Fatir bread 7 
 Glass, bowl, table spoon      Wheat flour  8 
 Bowl      Vermicelli(uncooked) 9 
 Spatula(usual, full), Plat      Spaghetti 10 
 Piece (30 gr)      Beef and lamb 11 
 Table spoon      Ground meat 12 
 Piece(30 gr)       Kidney, heart and liver 13 
 Leg, chest, arm, neck, all piece(L, M, S)*       Chicken with skin 14 
 Leg, chest, arm, neck, all piece(L, M, S)*      Chicken without skin 15 
 Number(30 gr)      Heart, liver and gizzard 16 
 One whole(60 gr)       Egg 17 
 150 gr      Fish 18 
 Can(200 gr)      Canned tuna fish 19 
*l= larg size, M= medium size, S= small size 
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unit Index 
Consumption per 
Never Food No. 
year month week day 
 One slice (30 gr)      Sussages  20 
 One slice (10gr)      kielbasa 21 
 Number(90gr)      Hamburger 22 
 Glass, cup      Pasteurized milk 23 
 Glass, cup      Raw milk 24 
 Matchbox size(30gr)      Pasteurized cheese 25 
 Matchbox size(30gr)      Rural cheese 26 
 Bowl, glass      Medium fat yoghurt  27 
 Bowl, glass      High fat yoghurt 28 
 Bowl, glass      Low fat yoghurt 29 
 Bowl, glass      Doogh (yoghurt drink) 30 
 Table spoon      Pasteurized curds 31 
 Bowl, glass      Navy been 32 
 Bowl, glass      Kidney been 33 
 Bowl, glass      Wax bean 34 
 Bowl, glass      Pea 35 
 Bowl, glass       Split pea 36 
 Bowl, glass      Soy bean 37 
 Bowl, glass      lentil 38 
 Matchbox size      Butter  39 
 Tea spoon, table spoon      Cream  40 
 Table spoon (semi full, full)      
Hydrogenated vegetable 
oil 
41 
 Table spoon      Vegetable oil 42 
 Table spoon      Mayonnaise  43 
 Table spoon      Olive oil 44 
 Chip, ring, cube      Fried potato 45 
 L, M, S*      Water cooked potato 46 
 L, M, S*      Uncooked tomato 47 
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unit Index 
Consumption per 
Never Food No. 
year month week day 
 L, M, S*      Cooked tomato 48 
 Table spoon      Tomato paste 49 
 L, M, S*      Eggplant  50 
 L, M, S*      Uncooked onion 51 
 L, M, S*      Cooked onion 52 
 Bowl (L, M, S*)      Leafy vegetables 53 
 Bowl, glass      Green bean 54 
 Bowl, glass      Green pea 55 
 Bowl, glass      Fava bean 56 
 Glass, leaf      lettuce 57 
 Slice       Squash  58 
 Slice        Cooked pumpkin 59 
 bowl      Cabbage leaf(chopped) 60 
 L, M, S*      Mushroom  61 
 L, M, S*      Green pepper 62 
 L, M, S*      Sweet pepper 63 
 L, M, S*      Uncooked carrot 64 
 L, M, S*      Cooked carrot 65 
 L, M, S*      Uncooked garlic (cloves) 66 
 Slice(L, M, S*)      watermelon 67 
 L, M, S*      Melon  68 
 L, M, S*      Cucumber  69 
 L, M, S*      Orange  70 
 L, M, S*      Tangin and other citrus 71 
 Glass       Grape  72 
 L, M, S*      Apple with peeling 73 
*l= larg size, M= medium size, S= small size 
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unit Index 
Consumption per 
Never Food No. 
year month week day 
 L, M, S*      Apple without peeling 74 
 Number(30gr)      Apricot  75 
 L, M, S*     
 
Plum  76 
 Glass(L, M, S*)      Cherry/sour cherry 77 
 L, M, S*      Peach 78 
 L, M, S*      Pear  79 
 Number(L, M, S*)      Dates  80 
 L, M, S*      Banana  81 
 L, M, S*      Pomegranate  82 
 Bowl, cup, table spoon      Raisin  83 
 Bowl, cup, table spoon      Barberry  84 
 20 medium size (17gr)      Dried mulberry  85 
 Number      Dried fig 86 
 Number      Dried prune  87 
 Number      Dried apricot  88 
 Bowl(with or without shell)      Peanut  89 
 L, M, S*      walnut 90 
 Bowl, number      Pistachio  91 
 cube      Cube sugar 92 
 Tea spoon, table spoon      Sugar  93 
 Tea spoon, table spoon      Honey  94 
 Tea spoon, table spoon      jam 95 
 Tea spoon, table spoon      Halwa  96 
 number      candy 97 
 number      Chocolate  98 
 40 gr      Sponge cake 99 
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unit Index 
Consumption per 
Never Food No. 
year month week day 
 Milliliter       Fruit juice  100 
 Glass       Conserved fruit 101 
 Bottle, glass      Carbonated drink  102 
 Glass, cup      Tea  103 
 
 
 
 
Name of questioner:                              signature:             date: 
 
Name of controller:                                signature:             date: 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
SHORT LAST 7 DAYS FORMAT 
 
For use with Young and Middle-aged Adults (15-69 years) 
I am going to ask you about the time you spent being physically active in the last 7 days. 
Please answer each question even if you do not consider yourself to be an active person.  
Think about the activities you do at work, as part of your house and yard work, to get 
from place to place, and in your spare time for recreation, exercise or sport. 
Now, think about all the vigorous activities which take hard physical effort that you did in 
the last 7 days.  Vigorous activities make you breathe much harder than normal and may 
include heavy lifting, digging, aerobics, or fast bicycling.  Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities? 
 _____  Days per week [VDAY; Range 0-7, 8,9]       
  8. Don't Know/Not Sure   
  9. Refused 
 [Interviewer clarification: Think only about those physical activities that you do for at 
least 10 minutes at a time.] 
[Interviewer note: If respondent answers zero, refuses or does not know, skip to 
Question 3] 
 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days?  
 __ __  Hours per day [VDHRS; Range: 0-16]  
 __ __ __ Minutes per day   [VDMIN; Range: 0-960, 998, 999]     
 998. Don't Know/Not Sure   
 999. Refused  
 
[Interviewer clarification: Think only about those physical activities you do for 
at least 10 minutes at a time.] 
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[Interviewer probe: An average time for one of the days on which you do 
vigorous activity is being sought. If the respondent can't answer because the 
pattern of time spent varies widely from day to day, ask: "How much time in 
total would you spend over the last 7 days doing vigorous physical activities?”  
__ __  Hours per week [VWHRS; Range: 0-112]     
 __ __ __ __Minutes per week [VWMIN; Range: 0-6720, 9998, 9999]   
 9998. Don't Know/Not Sure   
 9999. Refused   
    
Now think about activities which take moderate physical effort that you did in the last 7 
days.  Moderate physical activities make you breathe somewhat harder than normal and 
may include carrying light loads, bicycling at a regular pace, or doubles tennis.  Do not 
include walking.  Again, think about only those physical activities that you did for at least 
10 minutes at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities? 
 ____ Days per week     [MDAY; Range: 0-7, 8, 9]       
  8. Don't Know/Not Sure   
  9. Refused  
 [Interviewer clarification: Think only about those physical activities that you 
do for at least 10 minutes at a time] 
 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip 
to Question 5] 
4. How much time did you usually spend doing moderate physical activities on 
one of those days? 
 __ __ Hours per day  [MDHRS; Range: 0-16]       
 __ __ __ Minutes per day     [MDMIN; Range: 0-960, 998, 999]    
998. Don't Know/Not Sure   
  999. Refused   
 
[Interviewer clarification: Think only about those physical activities that you do 
for at least 10 minutes at a time.] 
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[Interviewer probe: An average time for one of the days on which you do 
moderate activity is being sought. If the respondent can't answer because the 
pattern of time spent varies widely from day to day, or includes time spent in 
multiple jobs, ask: “What is the total amount of time you spent over the last 7 
days doing moderate physical activities?” 
__ __ __  Hours per week   [MWHRS; Range: 0-112]   
__ __ __ __Minutes per week   [MWMIN; Range: 0-6720, 9998, 9999] 
9998. Don't Know/Not Sure   
 9999. Refused 
 
Now think about the time you spent walking in the last 7 days.  This includes at work and 
at home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time? 
____ Days per week  [WDAY; Range: 0-7, 8, 9]      
8. Don't Know/Not Sure   
 9. Refused   
 [Interviewer clarification: Think only about the walking that you do for at least 
10 minutes at a time.] 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip 
to Question 7] 
 
 6. How much time did you usually spend walking on one of those days? 
 __ __  Hours per day   [WDHRS; Range: 0-16]        
 __ __ __  Minutes per day [WDMIN; Range: 0-960, 998, 999]      
998. Don't Know/Not Sure   
 999. Refused 
  
[Interviewer probe: An average time for one of the days on which you walk is 
being sought.  If the respondent can't answer because the pattern of time spent 
varies widely from day to day, ask: “What is the total amount of time you spent 
walking over the last 7 days?” 
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             __ __ __   Hours per week [WWHRS; Range: 0-112]     
             __ __ __ __Minutes per week [WWMIN; Range: 0-6720, 9998, 9999]   
            9998. Don't Know/Not Sure   
 9999.Refused 
 
Now think about the time you spent sitting on week days during the last 7 days.  Include 
time spent at work, at home, while doing course work, and during leisure time.  This may 
include time spent sitting at a desk, visiting friends, reading or sitting or lying down to 
watch television. 
 
7. During the last 7 days, how much time did you usually spend sitting on a week 
day?  
 __ __  Hours per weekday [SDHRS; 0-16]                         
    __ __ __ Minutes per weekday    [SDMIN; Range: 0-960, 998, 999]   
998. Don't Know/Not Sure   
 999. Refused 
                                                                                           
[Interviewer clarification: Include time spent lying down (awake) as well as 
sitting] 
 
[Interviewer probe: An average time per day spent sitting is being sought.  If 
the respondent can't answer because the pattern of time spent varies widely 
from day to day, ask: “What is the total amount of time you spent sitting last 
Wednesday?” 
            __ __  Hours on Wednesday [SWHRS; Range 0-16]     
            __ __ __   Minutes on Wednesday [SWMIN; Range: 0-960, 998, 999]    
            998. Don't Know/Not Sure   
                       999. Refused 
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